id	sid	tid	token	lemma	pos
chd-200	1	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	VERB
chd-200	1	2	e1	e1	NOUN
chd-200	1	3	cancer	cancer	NOUN
chd-200	1	4	health	health	NOUN
chd-200	1	5	disparities	disparity	NOUN
chd-200	1	6	research	research	NOUN
chd-200	1	7	race	race	NOUN
chd-200	1	8	is	be	AUX
chd-200	1	9	related	relate	VERB
chd-200	1	10	with	with	ADP
chd-200	1	11	increased	increase	VERB
chd-200	1	12	covid-19	covid-19	PROPN
chd-200	1	13	infection	infection	NOUN
chd-200	1	14	in	in	ADP
chd-200	1	15	oncology	oncology	NOUN
chd-200	1	16	patients	patient	NOUN
chd-200	1	17	john	john	PROPN
chd-200	1	18	nakayama*a	nakayama*a	NUM
chd-200	1	19	,	,	PUNCT
chd-200	1	20	gino	gino	PROPN
chd-200	1	21	cioffib	cioffib	PROPN
chd-200	1	22	,	,	PUNCT
chd-200	1	23	i	i	PRON
chd-200	1	24	,	,	PUNCT
chd-200	1	25	sharanya	sharanya	PROPN
chd-200	1	26	iyerc	iyerc	PROPN
chd-200	1	27	,	,	PUNCT
chd-200	1	28	ravi	ravi	PROPN
chd-200	1	29	kumar	kumar	PROPN
chd-200	1	30	kyasaramd	kyasaramd	PROPN
chd-200	1	31	,	,	PUNCT
chd-200	1	32	john	john	PROPN
chd-200	1	33	shanahand	shanahand	PROPN
chd-200	1	34	,	,	PUNCT
chd-200	1	35	paolo	paolo	PROPN
chd-200	1	36	caimie	caimie	PROPN
chd-200	1	37	,	,	PUNCT
chd-200	1	38	kristin	kristin	PROPN
chd-200	1	39	a.	a.	NOUN
chd-200	1	40	waiteb	waiteb	PROPN
chd-200	1	41	,	,	PUNCT
chd-200	1	42	i	i	PRON
chd-200	1	43	,	,	PUNCT
chd-200	1	44	thomas	thomas	PROPN
chd-200	1	45	a.	a.	PROPN
chd-200	1	46	sellersf	sellersf	PROPN
chd-200	1	47	,	,	PUNCT
chd-200	1	48	jill	jill	PROPN
chd-200	1	49	s.	s.	PROPN
chd-200	1	50	barnholtz	barnholtz	PROPN
chd-200	1	51	-	-	PUNCT
chd-200	1	52	sloanb	sloanb	ADJ
chd-200	1	53	,	,	PUNCT
chd-200	1	54	g	g	PROPN
chd-200	1	55	,	,	PUNCT
chd-200	1	56	h	h	NOUN
chd-200	1	57	,	,	PUNCT
chd-200	1	58	i	i	PRON
chd-200	1	59	a	a	DET
chd-200	1	60	division	division	NOUN
chd-200	1	61	of	of	ADP
chd-200	1	62	gynecologic	gynecologic	ADJ
chd-200	1	63	oncology	oncology	NOUN
chd-200	1	64	,	,	PUNCT
chd-200	1	65	department	department	NOUN
chd-200	1	66	of	of	ADP
chd-200	1	67	obstetrics	obstetric	NOUN
chd-200	1	68	and	and	CCONJ
chd-200	1	69	gynecology	gynecology	NOUN
chd-200	1	70	university	university	NOUN
chd-200	1	71	hospitals	hospital	NOUN
chd-200	1	72	cleveland	cleveland	PROPN
chd-200	1	73	medical	medical	ADJ
chd-200	1	74	center	center	NOUN
chd-200	1	75	.	.	PUNCT
chd-200	2	1	cleveland	cleveland	PROPN
chd-200	2	2	,	,	PUNCT
chd-200	2	3	ohio	ohio	PROPN
chd-200	2	4	.	.	PUNCT
chd-200	3	1	usa	usa	PROPN
chd-200	3	2	b	b	PROPN
chd-200	3	3	department	department	PROPN
chd-200	3	4	of	of	ADP
chd-200	3	5	population	population	NOUN
chd-200	3	6	and	and	CCONJ
chd-200	3	7	quantitative	quantitative	ADJ
chd-200	3	8	health	health	NOUN
chd-200	3	9	sciences	science	NOUN
chd-200	3	10	,	,	PUNCT
chd-200	3	11	case	case	NOUN
chd-200	3	12	western	western	PROPN
chd-200	3	13	reserve	reserve	PROPN
chd-200	3	14	university	university	PROPN
chd-200	3	15	school	school	NOUN
chd-200	3	16	of	of	ADP
chd-200	3	17	medicine	medicine	NOUN
chd-200	3	18	.	.	PUNCT
chd-200	4	1	cleveland	cleveland	PROPN
chd-200	4	2	,	,	PUNCT
chd-200	4	3	ohio	ohio	PROPN
chd-200	4	4	.	.	PUNCT
chd-200	5	1	usa	usa	PROPN
chd-200	5	2	c	c	PROPN
chd-200	5	3	case	case	NOUN
chd-200	5	4	western	western	PROPN
chd-200	5	5	reserve	reserve	PROPN
chd-200	5	6	university	university	PROPN
chd-200	5	7	school	school	NOUN
chd-200	5	8	of	of	ADP
chd-200	5	9	medicine	medicine	NOUN
chd-200	5	10	.	.	PUNCT
chd-200	6	1	cleveland	cleveland	PROPN
chd-200	6	2	,	,	PUNCT
chd-200	6	3	ohio	ohio	PROPN
chd-200	6	4	.	.	PUNCT
chd-200	7	1	usa	usa	PROPN
chd-200	7	2	d	d	PROPN
chd-200	7	3	cancer	cancer	NOUN
chd-200	7	4	informatics	informatic	NOUN
chd-200	7	5	,	,	PUNCT
chd-200	7	6	seidman	seidman	NOUN
chd-200	7	7	cancer	cancer	NOUN
chd-200	7	8	center	center	PROPN
chd-200	7	9	.	.	PUNCT
chd-200	8	1	cleveland	cleveland	PROPN
chd-200	8	2	,	,	PUNCT
chd-200	8	3	ohio	ohio	PROPN
chd-200	8	4	.	.	PUNCT
chd-200	9	1	usa	usa	PROPN
chd-200	9	2	e	e	PROPN
chd-200	9	3	division	division	NOUN
chd-200	9	4	of	of	ADP
chd-200	9	5	hematology	hematology	NOUN
chd-200	9	6	,	,	PUNCT
chd-200	9	7	department	department	NOUN
chd-200	9	8	of	of	ADP
chd-200	9	9	medicine	medicine	NOUN
chd-200	9	10	,	,	PUNCT
chd-200	9	11	university	university	NOUN
chd-200	9	12	hospitals	hospital	NOUN
chd-200	9	13	seidman	seidman	NOUN
chd-200	9	14	cancer	cancer	NOUN
chd-200	9	15	center	center	PROPN
chd-200	9	16	.	.	PUNCT
chd-200	10	1	cleveland	cleveland	PROPN
chd-200	10	2	,	,	PUNCT
chd-200	10	3	ohio	ohio	PROPN
chd-200	10	4	.	.	PUNCT
chd-200	11	1	usa	usa	PROPN
chd-200	11	2	f	f	PROPN
chd-200	11	3	tas	ta	NOUN
chd-200	11	4	consulting	consulting	NOUN
chd-200	11	5	.	.	PUNCT
chd-200	12	1	tampa	tampa	PROPN
chd-200	12	2	,	,	PUNCT
chd-200	12	3	florida	florida	PROPN
chd-200	12	4	.	.	PUNCT
chd-200	13	1	usa	usa	PROPN
chd-200	13	2	g	g	PROPN
chd-200	13	3	case	case	NOUN
chd-200	13	4	comprehensive	comprehensive	ADJ
chd-200	13	5	cancer	cancer	NOUN
chd-200	13	6	center	center	NOUN
chd-200	13	7	.	.	PUNCT
chd-200	14	1	cleveland	cleveland	PROPN
chd-200	14	2	,	,	PUNCT
chd-200	14	3	ohio	ohio	PROPN
chd-200	14	4	.	.	PUNCT
chd-200	15	1	usa	usa	PROPN
chd-200	15	2	h	h	PROPN
chd-200	15	3	research	research	PROPN
chd-200	15	4	and	and	CCONJ
chd-200	15	5	education	education	NOUN
chd-200	15	6	division	division	NOUN
chd-200	15	7	,	,	PUNCT
chd-200	15	8	university	university	NOUN
chd-200	15	9	hospitals	hospital	NOUN
chd-200	15	10	of	of	ADP
chd-200	15	11	cleveland	cleveland	PROPN
chd-200	15	12	.	.	PUNCT
chd-200	16	1	cleveland	cleveland	PROPN
chd-200	16	2	,	,	PUNCT
chd-200	16	3	ohio	ohio	PROPN
chd-200	16	4	.	.	PUNCT
chd-200	17	1	usa	usa	PROPN
chd-200	17	2	i	i	PROPN
chd-200	17	3	cleveland	cleveland	PROPN
chd-200	17	4	center	center	PROPN
chd-200	17	5	for	for	ADP
chd-200	17	6	health	health	NOUN
chd-200	17	7	outcomes	outcome	NOUN
chd-200	17	8	research	research	NOUN
chd-200	17	9	(	(	PUNCT
chd-200	17	10	cchor	cchor	PROPN
chd-200	17	11	)	)	PUNCT
chd-200	17	12	.	.	PUNCT
chd-200	18	1	cleveland	cleveland	PROPN
chd-200	18	2	,	,	PUNCT
chd-200	18	3	ohio	ohio	PROPN
chd-200	18	4	.	.	PUNCT
chd-200	19	1	usa	usa	PROPN
chd-200	19	2	corresponding	corresponding	PROPN
chd-200	19	3	author	author	NOUN
chd-200	19	4	:	:	PUNCT
chd-200	19	5	john	john	PROPN
chd-200	19	6	nakayama	nakayama	PROPN
chd-200	19	7	.	.	PUNCT
chd-200	20	1	email	email	NOUN
chd-200	20	2	:	:	PUNCT
chd-200	20	3	john.nakayama@ahn.org	john.nakayama@ahn.org	PROPN
chd-200	20	4	abstract	abstract	NOUN
chd-200	20	5	we	we	PRON
chd-200	20	6	seek	seek	VERB
chd-200	20	7	to	to	PART
chd-200	20	8	assess	assess	VERB
chd-200	20	9	racial	racial	ADJ
chd-200	20	10	disparities	disparity	NOUN
chd-200	20	11	in	in	ADP
chd-200	20	12	oncology	oncology	NOUN
chd-200	20	13	patients	patient	NOUN
chd-200	20	14	with	with	ADP
chd-200	20	15	covid19	covid19	NOUN
chd-200	20	16	compared	compare	VERB
chd-200	20	17	to	to	ADP
chd-200	20	18	appropriately	appropriately	ADV
chd-200	20	19	matched	match	VERB
chd-200	20	20	controls	control	NOUN
chd-200	20	21	with	with	ADP
chd-200	20	22	and	and	CCONJ
chd-200	20	23	without	without	ADP
chd-200	20	24	covid19	covid19	NOUN
chd-200	20	25	.	.	PUNCT
chd-200	21	1	all	all	DET
chd-200	21	2	patients	patient	NOUN
chd-200	21	3	treated	treat	VERB
chd-200	21	4	at	at	ADP
chd-200	21	5	the	the	DET
chd-200	21	6	seidman	seidman	NOUN
chd-200	21	7	cancer	cancer	NOUN
chd-200	21	8	center	center	NOUN
chd-200	21	9	with	with	ADP
chd-200	21	10	a	a	DET
chd-200	21	11	diagnosis	diagnosis	NOUN
chd-200	21	12	of	of	ADP
chd-200	21	13	covid19	covid19	NOUN
chd-200	21	14	and	and	CCONJ
chd-200	21	15	cancer	cancer	NOUN
chd-200	21	16	were	be	AUX
chd-200	21	17	identified	identify	VERB
chd-200	21	18	from	from	ADP
chd-200	21	19	the	the	DET
chd-200	21	20	electronic	electronic	ADJ
chd-200	21	21	medical	medical	ADJ
chd-200	21	22	record	record	NOUN
chd-200	21	23	using	use	VERB
chd-200	21	24	icd9	icd9	PROPN
chd-200	21	25	/	/	SYM
chd-200	21	26	icd10	icd10	PROPN
chd-200	21	27	codes	code	NOUN
chd-200	21	28	for	for	ADP
chd-200	21	29	cancer	cancer	NOUN
chd-200	21	30	diagnoses	diagnosis	NOUN
chd-200	21	31	and	and	CCONJ
chd-200	21	32	database	database	NOUN
chd-200	21	33	of	of	ADP
chd-200	21	34	all	all	DET
chd-200	21	35	patients	patient	NOUN
chd-200	21	36	diagnosed	diagnose	VERB
chd-200	21	37	with	with	ADP
chd-200	21	38	covid19	covid19	NOUN
chd-200	21	39	.	.	PUNCT
chd-200	22	1	two	two	NUM
chd-200	22	2	control	control	NOUN
chd-200	22	3	groups	group	NOUN
chd-200	22	4	,	,	PUNCT
chd-200	22	5	cancer	cancer	NOUN
chd-200	22	6	patients	patient	NOUN
chd-200	22	7	without	without	ADP
chd-200	22	8	covid19	covid19	NOUN
chd-200	22	9	and	and	CCONJ
chd-200	22	10	patients	patient	NOUN
chd-200	22	11	without	without	ADP
chd-200	22	12	cancer	cancer	NOUN
chd-200	22	13	but	but	CCONJ
chd-200	22	14	with	with	ADP
chd-200	22	15	covid19	covid19	NOUN
chd-200	22	16	,	,	PUNCT
chd-200	22	17	were	be	AUX
chd-200	22	18	generated	generate	VERB
chd-200	22	19	and	and	CCONJ
chd-200	22	20	matched	match	VERB
chd-200	22	21	3:1	3:1	NUM
chd-200	22	22	on	on	ADP
chd-200	22	23	age	age	NOUN
chd-200	22	24	at	at	ADP
chd-200	22	25	date	date	NOUN
chd-200	22	26	of	of	ADP
chd-200	22	27	data	data	NOUN
chd-200	22	28	extraction	extraction	NOUN
chd-200	22	29	,	,	PUNCT
chd-200	22	30	age	age	NOUN
chd-200	22	31	at	at	ADP
chd-200	22	32	cancer	cancer	NOUN
chd-200	22	33	diagnosis	diagnosis	NOUN
chd-200	22	34	,	,	PUNCT
chd-200	22	35	and	and	CCONJ
chd-200	22	36	sex	sex	NOUN
chd-200	22	37	to	to	AUX
chd-200	22	38	covid19	covid19	VERB
chd-200	22	39	positive	positive	ADJ
chd-200	22	40	cancer	cancer	NOUN
chd-200	22	41	cases	case	NOUN
chd-200	22	42	.	.	PUNCT
chd-200	23	1	african	african	ADJ
chd-200	23	2	americans	americans	PROPN
chd-200	23	3	(	(	PUNCT
chd-200	23	4	aa	aa	NOUN
chd-200	23	5	)	)	PUNCT
chd-200	23	6	and	and	CCONJ
chd-200	23	7	whites	white	NOUN
chd-200	23	8	made	make	VERB
chd-200	23	9	up	up	ADP
chd-200	23	10	8.6	8.6	NUM
chd-200	23	11	%	%	NOUN
chd-200	23	12	vs.	vs.	ADP
chd-200	23	13	76.9	76.9	NUM
chd-200	23	14	%	%	NOUN
chd-200	23	15	of	of	ADP
chd-200	23	16	the	the	DET
chd-200	23	17	baseline	baseline	ADJ
chd-200	23	18	oncologic	oncologic	ADJ
chd-200	23	19	population	population	NOUN
chd-200	23	20	without	without	ADP
chd-200	23	21	covid19	covid19	NOUN
chd-200	23	22	,	,	PUNCT
chd-200	23	23	respectively	respectively	ADV
chd-200	23	24	.	.	PUNCT
chd-200	24	1	aa	aa	PROPN
chd-200	24	2	representation	representation	PROPN
chd-200	24	3	(	(	PUNCT
chd-200	24	4	41.0	41.0	NUM
chd-200	24	5	%	%	NOUN
chd-200	24	6	)	)	PUNCT
chd-200	24	7	was	be	AUX
chd-200	24	8	significantly	significantly	ADV
chd-200	24	9	increased	increase	VERB
chd-200	24	10	in	in	ADP
chd-200	24	11	cancer	cancer	NOUN
chd-200	24	12	patients	patient	NOUN
chd-200	24	13	positive	positive	ADJ
chd-200	24	14	for	for	ADP
chd-200	24	15	covid19	covid19	NOUN
chd-200	24	16	compared	compare	VERB
chd-200	24	17	to	to	ADP
chd-200	24	18	those	those	PRON
chd-200	24	19	negative	negative	ADJ
chd-200	24	20	for	for	ADP
chd-200	24	21	covid19	covid19	NOUN
chd-200	24	22	(	(	PUNCT
chd-200	24	23	p<0.001	p<0.001	PROPN
chd-200	24	24	)	)	PUNCT
chd-200	24	25	.	.	PUNCT
chd-200	25	1	in	in	ADP
chd-200	25	2	the	the	DET
chd-200	25	3	comparison	comparison	NOUN
chd-200	25	4	of	of	ADP
chd-200	25	5	patients	patient	NOUN
chd-200	25	6	with	with	ADP
chd-200	25	7	covid19	covid19	NOUN
chd-200	25	8	with	with	ADP
chd-200	25	9	or	or	CCONJ
chd-200	25	10	without	without	ADP
chd-200	25	11	cancer	cancer	NOUN
chd-200	25	12	,	,	PUNCT
chd-200	25	13	the	the	DET
chd-200	25	14	proportion	proportion	NOUN
chd-200	25	15	of	of	ADP
chd-200	25	16	aa	aa	NOUN
chd-200	25	17	cases	case	NOUN
chd-200	25	18	was	be	AUX
chd-200	25	19	greater	great	ADJ
chd-200	25	20	in	in	ADP
chd-200	25	21	the	the	DET
chd-200	25	22	nononcologic	nononcologic	ADJ
chd-200	25	23	population	population	NOUN
chd-200	25	24	(	(	PUNCT
chd-200	25	25	41.0	41.0	NUM
chd-200	25	26	%	%	NOUN
chd-200	25	27	vs.	vs.	ADP
chd-200	25	28	47.6	47.6	NUM
chd-200	25	29	%	%	NOUN
chd-200	25	30	,	,	PUNCT
chd-200	25	31	p=0.014	p=0.014	PROPN
chd-200	25	32	)	)	PUNCT
chd-200	25	33	.	.	PUNCT
chd-200	26	1	aa	aa	PROPN
chd-200	26	2	are	be	AUX
chd-200	26	3	disproportionately	disproportionately	ADV
chd-200	26	4	affected	affect	VERB
chd-200	26	5	with	with	ADP
chd-200	26	6	covid19	covid19	NOUN
chd-200	26	7	in	in	ADP
chd-200	26	8	oncologic	oncologic	ADJ
chd-200	26	9	and	and	CCONJ
chd-200	26	10	benign	benign	ADJ
chd-200	26	11	populations	population	NOUN
chd-200	26	12	.	.	PUNCT
chd-200	27	1	despite	despite	SCONJ
chd-200	27	2	similar	similar	ADJ
chd-200	27	3	rates	rate	NOUN
chd-200	27	4	of	of	ADP
chd-200	27	5	adverse	adverse	ADJ
chd-200	27	6	outcomes	outcome	NOUN
chd-200	27	7	to	to	PART
chd-200	27	8	covid19	covid19	VERB
chd-200	27	9	in	in	ADP
chd-200	27	10	cancer	cancer	NOUN
chd-200	27	11	patients	patient	NOUN
chd-200	27	12	by	by	ADP
chd-200	27	13	race	race	NOUN
chd-200	27	14	,	,	PUNCT
chd-200	27	15	we	we	PRON
chd-200	27	16	found	find	VERB
chd-200	27	17	a	a	DET
chd-200	27	18	32.4	32.4	NUM
chd-200	27	19	%	%	NOUN
chd-200	27	20	increase	increase	NOUN
chd-200	27	21	in	in	ADP
chd-200	27	22	the	the	DET
chd-200	27	23	aa	aa	NOUN
chd-200	27	24	proportion	proportion	NOUN
chd-200	27	25	compared	compare	VERB
chd-200	27	26	to	to	ADP
chd-200	27	27	those	those	PRON
chd-200	27	28	without	without	ADP
chd-200	27	29	covid19	covid19	NOUN
chd-200	27	30	.	.	PUNCT
chd-200	28	1	these	these	DET
chd-200	28	2	findings	finding	NOUN
chd-200	28	3	suggest	suggest	VERB
chd-200	28	4	covid19	covid19	NOUN
chd-200	28	5	prevention	prevention	NOUN
chd-200	28	6	policies	policy	NOUN
chd-200	28	7	and	and	CCONJ
chd-200	28	8	future	future	ADJ
chd-200	28	9	studies	study	NOUN
chd-200	28	10	should	should	AUX
chd-200	28	11	account	account	VERB
chd-200	28	12	for	for	ADP
chd-200	28	13	racial	racial	ADJ
chd-200	28	14	differences	difference	NOUN
chd-200	28	15	in	in	ADP
chd-200	28	16	the	the	DET
chd-200	28	17	oncology	oncology	NOUN
chd-200	28	18	population	population	NOUN
chd-200	28	19	.	.	PUNCT
chd-200	29	1	keywords	keyword	NOUN
chd-200	29	2	:	:	PUNCT
chd-200	29	3	covid19	covid19	PROPN
chd-200	29	4	,	,	PUNCT
chd-200	29	5	coronavirus	coronavirus	NOUN
chd-200	29	6	19	19	NUM
chd-200	29	7	,	,	PUNCT
chd-200	29	8	racial	racial	ADJ
chd-200	29	9	disparities	disparity	NOUN
chd-200	29	10	,	,	PUNCT
chd-200	29	11	oncology	oncology	NOUN
chd-200	29	12	,	,	PUNCT
chd-200	29	13	citation	citation	NOUN
chd-200	29	14	:	:	PUNCT
chd-200	29	15	nakayama	nakayama	PROPN
chd-200	29	16	j	j	PROPN
chd-200	29	17	et	et	PROPN
chd-200	29	18	al	al	PROPN
chd-200	29	19	(	(	PUNCT
chd-200	29	20	2021	2021	NUM
chd-200	29	21	)	)	PUNCT
chd-200	29	22	race	race	NOUN
chd-200	29	23	is	be	AUX
chd-200	29	24	related	relate	VERB
chd-200	29	25	with	with	ADP
chd-200	29	26	increased	increase	VERB
chd-200	29	27	covid-19	covid-19	PROPN
chd-200	29	28	infection	infection	NOUN
chd-200	29	29	in	in	ADP
chd-200	29	30	oncology	oncology	NOUN
chd-200	29	31	patients	patient	NOUN
chd-200	29	32	.	.	PUNCT
chd-200	30	1	cancer	cancer	NOUN
chd-200	30	2	health	health	NOUN
chd-200	30	3	disparities	disparity	NOUN
chd-200	30	4	5	5	NUM
chd-200	30	5	:	:	PUNCT
chd-200	30	6	e1	e1	NOUN
chd-200	30	7	-	-	PUNCT
chd-200	30	8	e8.doi:10.9777	e8.doi:10.9777	PROPN
chd-200	30	9	/	/	SYM
chd-200	30	10	chd.2021.1004	chd.2021.1004	PROPN
chd-200	30	11	mailto:john.nakayama@ahn.org	mailto:john.nakayama@ahn.org	ADJ
chd-200	30	12	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-200	30	13	e2	e2	PROPN
chd-200	30	14	cancer	cancer	NOUN
chd-200	30	15	health	health	NOUN
chd-200	30	16	disparities	disparity	NOUN
chd-200	30	17	research	research	NOUN
chd-200	30	18	introduction	introduction	NOUN
chd-200	30	19	the	the	DET
chd-200	30	20	novel	novel	ADJ
chd-200	30	21	coronavirus	coronavirus	NOUN
chd-200	30	22	sars	sar	NOUN
chd-200	30	23	-	-	PUNCT
chd-200	30	24	cov-2	cov-2	PART
chd-200	30	25	(	(	PUNCT
chd-200	30	26	covid19	covid19	NOUN
chd-200	30	27	)	)	PUNCT
chd-200	30	28	pandemic	pandemic	NOUN
chd-200	30	29	led	lead	VERB
chd-200	30	30	to	to	ADP
chd-200	30	31	radical	radical	ADJ
chd-200	30	32	shifts	shift	NOUN
chd-200	30	33	in	in	ADP
chd-200	30	34	oncology	oncology	NOUN
chd-200	30	35	care	care	NOUN
chd-200	30	36	.	.	PUNCT
chd-200	31	1	new	new	ADJ
chd-200	31	2	reports	report	NOUN
chd-200	31	3	indicate	indicate	VERB
chd-200	31	4	that	that	SCONJ
chd-200	31	5	cancer	cancer	NOUN
chd-200	31	6	patients	patient	NOUN
chd-200	31	7	have	have	AUX
chd-200	31	8	increased	increase	VERB
chd-200	31	9	morbidity	morbidity	NOUN
chd-200	31	10	and	and	CCONJ
chd-200	31	11	mortality	mortality	NOUN
chd-200	31	12	from	from	ADP
chd-200	31	13	covid191–4	covid191–4	NOUN
chd-200	31	14	.	.	PUNCT
chd-200	32	1	one	one	NUM
chd-200	32	2	study	study	NOUN
chd-200	32	3	from	from	ADP
chd-200	32	4	new	new	PROPN
chd-200	32	5	york	york	PROPN
chd-200	32	6	,	,	PUNCT
chd-200	32	7	showed	show	VERB
chd-200	32	8	40	40	NUM
chd-200	32	9	%	%	NOUN
chd-200	32	10	of	of	ADP
chd-200	32	11	cancer	cancer	NOUN
chd-200	32	12	patients	patient	NOUN
chd-200	32	13	with	with	ADP
chd-200	32	14	covid19	covid19	NOUN
chd-200	32	15	required	require	VERB
chd-200	32	16	hospital	hospital	NOUN
chd-200	32	17	admission	admission	NOUN
chd-200	32	18	.	.	PUNCT
chd-200	33	1	older	old	ADJ
chd-200	33	2	age	age	NOUN
chd-200	33	3	(	(	PUNCT
chd-200	33	4	>	>	SYM
chd-200	33	5	65	65	NUM
chd-200	33	6	years	year	NOUN
chd-200	33	7	)	)	PUNCT
chd-200	33	8	and	and	CCONJ
chd-200	33	9	recent	recent	ADJ
chd-200	33	10	immunotherapy	immunotherapy	NOUN
chd-200	33	11	predicted	predict	VERB
chd-200	33	12	admission	admission	NOUN
chd-200	33	13	and	and	CCONJ
chd-200	33	14	disease	disease	NOUN
chd-200	33	15	severity	severity	NOUN
chd-200	33	16	while	while	SCONJ
chd-200	33	17	chemotherapy	chemotherapy	NOUN
chd-200	33	18	or	or	CCONJ
chd-200	33	19	surgery	surgery	NOUN
chd-200	33	20	did	do	VERB
chd-200	33	21	not5	not5	NOUN
chd-200	33	22	.	.	PUNCT
chd-200	34	1	these	these	DET
chd-200	34	2	findings	finding	NOUN
chd-200	34	3	may	may	AUX
chd-200	34	4	not	not	PART
chd-200	34	5	be	be	AUX
chd-200	34	6	generalizable	generalizable	ADJ
chd-200	34	7	given	give	VERB
chd-200	34	8	that	that	SCONJ
chd-200	34	9	the	the	DET
chd-200	34	10	proportion	proportion	NOUN
chd-200	34	11	of	of	ADP
chd-200	34	12	minority	minority	NOUN
chd-200	34	13	subjects	subject	NOUN
chd-200	34	14	was	be	AUX
chd-200	34	15	lower	low	ADJ
chd-200	34	16	than	than	ADP
chd-200	34	17	other	other	ADJ
chd-200	34	18	studies	study	NOUN
chd-200	34	19	conducted	conduct	VERB
chd-200	34	20	in	in	ADP
chd-200	34	21	the	the	DET
chd-200	34	22	same	same	ADJ
chd-200	34	23	area3,6	area3,6	PROPN
chd-200	34	24	.	.	PUNCT
chd-200	35	1	in	in	ADP
chd-200	35	2	an	an	DET
chd-200	35	3	attempt	attempt	NOUN
chd-200	35	4	to	to	PART
chd-200	35	5	overcome	overcome	VERB
chd-200	35	6	some	some	PRON
chd-200	35	7	of	of	ADP
chd-200	35	8	the	the	DET
chd-200	35	9	limitations	limitation	NOUN
chd-200	35	10	of	of	ADP
chd-200	35	11	prior	prior	ADJ
chd-200	35	12	studies	study	NOUN
chd-200	35	13	,	,	PUNCT
chd-200	35	14	a	a	DET
chd-200	35	15	case	case	NOUN
chd-200	35	16	control	control	NOUN
chd-200	35	17	study	study	NOUN
chd-200	35	18	of	of	ADP
chd-200	35	19	chinese	chinese	ADJ
chd-200	35	20	covid19	covid19	NOUN
chd-200	35	21	patients	patient	NOUN
chd-200	35	22	with	with	ADP
chd-200	35	23	and	and	CCONJ
chd-200	35	24	without	without	ADP
chd-200	35	25	cancer	cancer	NOUN
chd-200	35	26	was	be	AUX
chd-200	35	27	performed	perform	VERB
chd-200	35	28	.	.	PUNCT
chd-200	36	1	it	it	PRON
chd-200	36	2	showed	show	VERB
chd-200	36	3	oncology	oncology	NOUN
chd-200	36	4	patients	patient	NOUN
chd-200	36	5	had	have	VERB
chd-200	36	6	a	a	DET
chd-200	36	7	nearly	nearly	ADV
chd-200	36	8	significant	significant	ADJ
chd-200	36	9	increased	increase	VERB
chd-200	36	10	risk	risk	NOUN
chd-200	36	11	of	of	ADP
chd-200	36	12	death	death	NOUN
chd-200	36	13	(	(	PUNCT
chd-200	36	14	or	or	CCONJ
chd-200	36	15	:	:	PUNCT
chd-200	36	16	2.17	2.17	NUM
chd-200	36	17	,	,	PUNCT
chd-200	36	18	p=	p=	NOUN
chd-200	36	19	0.06	0.06	NUM
chd-200	36	20	)	)	PUNCT
chd-200	36	21	and	and	CCONJ
chd-200	36	22	significantly	significantly	ADV
chd-200	36	23	more	more	ADV
chd-200	36	24	icu	icu	PROPN
chd-200	36	25	admissions	admission	NOUN
chd-200	36	26	(	(	PUNCT
chd-200	36	27	or	or	CCONJ
chd-200	36	28	:	:	PUNCT
chd-200	36	29	3.13	3.13	NUM
chd-200	36	30	,	,	PUNCT
chd-200	36	31	p<0.01	p<0.01	PROPN
chd-200	36	32	)	)	PUNCT
chd-200	36	33	or	or	CCONJ
chd-200	36	34	at	at	ADV
chd-200	36	35	least	least	ADJ
chd-200	36	36	one	one	NUM
chd-200	36	37	severe	severe	ADJ
chd-200	36	38	symptom	symptom	NOUN
chd-200	36	39	(	(	PUNCT
chd-200	36	40	or	or	CCONJ
chd-200	36	41	:	:	PUNCT
chd-200	36	42	1.99	1.99	NUM
chd-200	36	43	,	,	PUNCT
chd-200	36	44	p<0.01)7	p<0.01)7	NOUN
chd-200	36	45	.	.	PUNCT
chd-200	37	1	cancer	cancer	NOUN
chd-200	37	2	patients	patient	NOUN
chd-200	37	3	are	be	AUX
chd-200	37	4	often	often	ADV
chd-200	37	5	obliged	oblige	VERB
chd-200	37	6	to	to	PART
chd-200	37	7	continue	continue	VERB
chd-200	37	8	care	care	NOUN
chd-200	37	9	.	.	PUNCT
chd-200	38	1	during	during	ADP
chd-200	38	2	the	the	DET
chd-200	38	3	covid19	covid19	NOUN
chd-200	38	4	pandemic	pandemic	NOUN
chd-200	38	5	this	this	PRON
chd-200	38	6	can	can	AUX
chd-200	38	7	be	be	AUX
chd-200	38	8	dangerous	dangerous	ADJ
chd-200	38	9	for	for	ADP
chd-200	38	10	patients	patient	NOUN
chd-200	38	11	who	who	PRON
chd-200	38	12	lack	lack	VERB
chd-200	38	13	the	the	DET
chd-200	38	14	resources	resource	NOUN
chd-200	38	15	or	or	CCONJ
chd-200	38	16	ability	ability	NOUN
chd-200	38	17	to	to	PART
chd-200	38	18	limit	limit	VERB
chd-200	38	19	their	their	PRON
chd-200	38	20	exposure	exposure	NOUN
chd-200	38	21	.	.	PUNCT
chd-200	39	1	while	while	SCONJ
chd-200	39	2	higher	high	ADJ
chd-200	39	3	covid19	covid19	NOUN
chd-200	39	4	infection	infection	NOUN
chd-200	39	5	rates	rate	NOUN
chd-200	39	6	have	have	AUX
chd-200	39	7	been	be	AUX
chd-200	39	8	observed	observe	VERB
chd-200	39	9	in	in	ADP
chd-200	39	10	minority	minority	NOUN
chd-200	39	11	communities	community	NOUN
chd-200	39	12	through	through	ADP
chd-200	39	13	the	the	DET
chd-200	39	14	lay	lay	ADJ
chd-200	39	15	press	press	NOUN
chd-200	39	16	and	and	CCONJ
chd-200	39	17	editorials	editorial	NOUN
chd-200	39	18	,	,	PUNCT
chd-200	39	19	a	a	DET
chd-200	39	20	limited	limited	ADJ
chd-200	39	21	body	body	NOUN
chd-200	39	22	of	of	ADP
chd-200	39	23	scientific	scientific	ADJ
chd-200	39	24	literature	literature	NOUN
chd-200	39	25	is	be	AUX
chd-200	39	26	available3,8	available3,8	PROPN
chd-200	39	27	.	.	PUNCT
chd-200	40	1	a	a	DET
chd-200	40	2	recent	recent	ADJ
chd-200	40	3	study	study	NOUN
chd-200	40	4	using	use	VERB
chd-200	40	5	veteran	veteran	NOUN
chd-200	40	6	’s	’s	PART
chd-200	40	7	affairs	affair	NOUN
chd-200	40	8	(	(	PUNCT
chd-200	40	9	va	va	NOUN
chd-200	40	10	)	)	PUNCT
chd-200	40	11	data	datum	NOUN
chd-200	40	12	showed	show	VERB
chd-200	40	13	a	a	DET
chd-200	40	14	higher	high	ADJ
chd-200	40	15	prevalence	prevalence	NOUN
chd-200	40	16	of	of	ADP
chd-200	40	17	covid19	covid19	NOUN
chd-200	40	18	infection	infection	NOUN
chd-200	40	19	and	and	CCONJ
chd-200	40	20	hospitalization	hospitalization	NOUN
chd-200	40	21	,	,	PUNCT
chd-200	40	22	but	but	CCONJ
chd-200	40	23	not	not	PART
chd-200	40	24	mortality	mortality	NOUN
chd-200	40	25	,	,	PUNCT
chd-200	40	26	in	in	ADP
chd-200	40	27	african	african	ADJ
chd-200	40	28	americans	americans	PROPN
chd-200	40	29	(	(	PUNCT
chd-200	40	30	aa)9	aa)9	PROPN
chd-200	40	31	.	.	PUNCT
chd-200	41	1	this	this	DET
chd-200	41	2	data	datum	NOUN
chd-200	41	3	may	may	AUX
chd-200	41	4	not	not	PART
chd-200	41	5	be	be	AUX
chd-200	41	6	generalizable	generalizable	ADJ
chd-200	41	7	due	due	ADP
chd-200	41	8	to	to	ADP
chd-200	41	9	the	the	DET
chd-200	41	10	unique	unique	ADJ
chd-200	41	11	va	va	NOUN
chd-200	41	12	population	population	NOUN
chd-200	41	13	.	.	PUNCT
chd-200	42	1	given	give	VERB
chd-200	42	2	these	these	DET
chd-200	42	3	realities	reality	NOUN
chd-200	42	4	and	and	CCONJ
chd-200	42	5	the	the	DET
chd-200	42	6	racially	racially	ADV
chd-200	42	7	diverse	diverse	ADJ
chd-200	42	8	population	population	NOUN
chd-200	42	9	of	of	ADP
chd-200	42	10	the	the	DET
chd-200	42	11	university	university	NOUN
chd-200	42	12	hospitals	hospital	NOUN
chd-200	42	13	seidman	seidman	NOUN
chd-200	42	14	cancer	cancer	NOUN
chd-200	42	15	center	center	NOUN
chd-200	42	16	(	(	PUNCT
chd-200	42	17	uhscc	uhscc	ADJ
chd-200	42	18	)	)	PUNCT
chd-200	42	19	,	,	PUNCT
chd-200	42	20	we	we	PRON
chd-200	42	21	investigated	investigate	VERB
chd-200	42	22	the	the	DET
chd-200	42	23	dynamics	dynamic	NOUN
chd-200	42	24	of	of	ADP
chd-200	42	25	covid19	covid19	NOUN
chd-200	42	26	infection	infection	NOUN
chd-200	42	27	in	in	ADP
chd-200	42	28	oncology	oncology	NOUN
chd-200	42	29	patients	patient	NOUN
chd-200	42	30	in	in	ADP
chd-200	42	31	order	order	NOUN
chd-200	42	32	to	to	PART
chd-200	42	33	:	:	PUNCT
chd-200	42	34	(	(	PUNCT
chd-200	42	35	1	1	X
chd-200	42	36	)	)	PUNCT
chd-200	42	37	determine	determine	VERB
chd-200	42	38	the	the	DET
chd-200	42	39	demographic	demographic	ADJ
chd-200	42	40	differences	difference	NOUN
chd-200	42	41	between	between	ADP
chd-200	42	42	cancer	cancer	NOUN
chd-200	42	43	patients	patient	NOUN
chd-200	42	44	infected	infect	VERB
chd-200	42	45	with	with	ADP
chd-200	42	46	covid19	covid19	NOUN
chd-200	42	47	versus	versus	ADP
chd-200	42	48	covid19	covid19	NOUN
chd-200	42	49	infected	infect	VERB
chd-200	42	50	patients	patient	NOUN
chd-200	42	51	without	without	ADP
chd-200	42	52	a	a	DET
chd-200	42	53	cancer	cancer	NOUN
chd-200	42	54	history	history	NOUN
chd-200	42	55	,	,	PUNCT
chd-200	42	56	(	(	PUNCT
chd-200	42	57	2	2	X
chd-200	42	58	)	)	PUNCT
chd-200	42	59	compare	compare	VERB
chd-200	42	60	the	the	DET
chd-200	42	61	outcomes	outcome	NOUN
chd-200	42	62	of	of	ADP
chd-200	42	63	cancer	cancer	NOUN
chd-200	42	64	patients	patient	NOUN
chd-200	42	65	infected	infect	VERB
chd-200	42	66	with	with	ADP
chd-200	42	67	covid19	covid19	NOUN
chd-200	42	68	to	to	ADP
chd-200	42	69	patients	patient	NOUN
chd-200	42	70	without	without	ADP
chd-200	42	71	cancer	cancer	NOUN
chd-200	42	72	who	who	PRON
chd-200	42	73	are	be	AUX
chd-200	42	74	infected	infect	VERB
chd-200	42	75	with	with	ADP
chd-200	42	76	covid19	covid19	NOUN
chd-200	42	77	,	,	PUNCT
chd-200	42	78	and	and	CCONJ
chd-200	42	79	(	(	PUNCT
chd-200	42	80	3	3	X
chd-200	42	81	)	)	PUNCT
chd-200	42	82	compare	compare	NOUN
chd-200	42	83	characteristics	characteristic	NOUN
chd-200	42	84	and	and	CCONJ
chd-200	42	85	outcomes	outcome	NOUN
chd-200	42	86	of	of	ADP
chd-200	42	87	cancer	cancer	NOUN
chd-200	42	88	patients	patient	NOUN
chd-200	42	89	infected	infect	VERB
chd-200	42	90	with	with	ADP
chd-200	42	91	covid19	covid19	NOUN
chd-200	42	92	to	to	ADP
chd-200	42	93	cancer	cancer	NOUN
chd-200	42	94	patients	patient	NOUN
chd-200	42	95	without	without	ADP
chd-200	42	96	covid19	covid19	NOUN
chd-200	42	97	diagnosis	diagnosis	NOUN
chd-200	42	98	.	.	PUNCT
chd-200	43	1	materials	material	NOUN
chd-200	43	2	and	and	CCONJ
chd-200	43	3	methods	method	NOUN
chd-200	43	4	after	after	ADP
chd-200	43	5	receiving	receive	VERB
chd-200	43	6	approval	approval	NOUN
chd-200	43	7	by	by	ADP
chd-200	43	8	uhscc	uhscc	ADJ
chd-200	43	9	institutional	institutional	ADJ
chd-200	43	10	review	review	NOUN
chd-200	43	11	board	board	NOUN
chd-200	43	12	,	,	PUNCT
chd-200	43	13	a	a	DET
chd-200	43	14	search	search	NOUN
chd-200	43	15	from	from	ADP
chd-200	43	16	3/16/2020	3/16/2020	NUM
chd-200	43	17	to	to	ADP
chd-200	43	18	7/7/2020	7/7/2020	NUM
chd-200	43	19	was	be	AUX
chd-200	43	20	performed	perform	VERB
chd-200	43	21	of	of	ADP
chd-200	43	22	all	all	DET
chd-200	43	23	patients	patient	NOUN
chd-200	43	24	treated	treat	VERB
chd-200	43	25	at	at	ADP
chd-200	43	26	the	the	DET
chd-200	43	27	seidman	seidman	NOUN
chd-200	43	28	cancer	cancer	NOUN
chd-200	43	29	center	center	NOUN
chd-200	43	30	.	.	PUNCT
chd-200	44	1	a	a	DET
chd-200	44	2	cancer	cancer	NOUN
chd-200	44	3	diagnosis	diagnosis	NOUN
chd-200	44	4	was	be	AUX
chd-200	44	5	determined	determine	VERB
chd-200	44	6	by	by	ADP
chd-200	44	7	searching	search	VERB
chd-200	44	8	the	the	DET
chd-200	44	9	electronic	electronic	ADJ
chd-200	44	10	medical	medical	ADJ
chd-200	44	11	record	record	NOUN
chd-200	44	12	for	for	ADP
chd-200	44	13	a	a	DET
chd-200	44	14	cancer	cancer	NOUN
chd-200	44	15	icd9/10	icd9/10	VERB
chd-200	44	16	code	code	NOUN
chd-200	44	17	and	and	CCONJ
chd-200	44	18	then	then	ADV
chd-200	44	19	manually	manually	ADV
chd-200	44	20	verifying	verify	VERB
chd-200	44	21	the	the	DET
chd-200	44	22	cancer	cancer	NOUN
chd-200	44	23	diagnosis	diagnosis	NOUN
chd-200	44	24	.	.	PUNCT
chd-200	45	1	covid19	covid19	NOUN
chd-200	45	2	positive	positive	ADJ
chd-200	45	3	patients	patient	NOUN
chd-200	45	4	were	be	AUX
chd-200	45	5	identified	identify	VERB
chd-200	45	6	using	use	VERB
chd-200	45	7	a	a	DET
chd-200	45	8	database	database	NOUN
chd-200	45	9	maintained	maintain	VERB
chd-200	45	10	by	by	ADP
chd-200	45	11	the	the	DET
chd-200	45	12	hospital	hospital	NOUN
chd-200	45	13	of	of	ADP
chd-200	45	14	all	all	DET
chd-200	45	15	patients	patient	NOUN
chd-200	45	16	diagnosed	diagnose	VERB
chd-200	45	17	with	with	ADP
chd-200	45	18	covid19	covid19	NOUN
chd-200	45	19	.	.	PUNCT
chd-200	46	1	adult	adult	NOUN
chd-200	46	2	(	(	PUNCT
chd-200	46	3	>	>	X
chd-200	46	4	18years	18years	NUM
chd-200	46	5	old	old	ADJ
chd-200	46	6	)	)	PUNCT
chd-200	46	7	,	,	PUNCT
chd-200	46	8	covid19	covid19	NOUN
chd-200	46	9	positive	positive	ADJ
chd-200	46	10	oncology	oncology	NOUN
chd-200	46	11	patients	patient	NOUN
chd-200	46	12	were	be	AUX
chd-200	46	13	identified	identify	VERB
chd-200	46	14	(	(	PUNCT
chd-200	46	15	ca+/covid+	ca+/covid+	PROPN
chd-200	46	16	)	)	PUNCT
chd-200	46	17	.	.	PUNCT
chd-200	47	1	two	two	NUM
chd-200	47	2	control	control	NOUN
chd-200	47	3	groups	group	NOUN
chd-200	47	4	,	,	PUNCT
chd-200	47	5	cancer	cancer	NOUN
chd-200	47	6	patients	patient	NOUN
chd-200	47	7	without	without	ADP
chd-200	47	8	covid19	covid19	NOUN
chd-200	47	9	(	(	PUNCT
chd-200	47	10	ca+/covid-	ca+/covid-	PROPN
chd-200	47	11	)	)	PUNCT
chd-200	47	12	and	and	CCONJ
chd-200	47	13	patients	patient	NOUN
chd-200	47	14	without	without	ADP
chd-200	47	15	cancer	cancer	NOUN
chd-200	47	16	but	but	CCONJ
chd-200	47	17	with	with	ADP
chd-200	47	18	covid19	covid19	NOUN
chd-200	47	19	(	(	PUNCT
chd-200	47	20	ca	ca	NOUN
chd-200	47	21	/	/	SYM
chd-200	47	22	covid+	covid+	NOUN
chd-200	47	23	)	)	PUNCT
chd-200	47	24	,	,	PUNCT
chd-200	47	25	were	be	AUX
chd-200	47	26	generated	generate	VERB
chd-200	47	27	.	.	PUNCT
chd-200	48	1	the	the	DET
chd-200	48	2	ca+/covid	ca+/covid	PROPN
chd-200	48	3	group	group	NOUN
chd-200	48	4	was	be	AUX
chd-200	48	5	matched	match	VERB
chd-200	48	6	based	base	VERB
chd-200	48	7	upon	upon	SCONJ
chd-200	48	8	age	age	NOUN
chd-200	48	9	at	at	ADP
chd-200	48	10	date	date	NOUN
chd-200	48	11	of	of	ADP
chd-200	48	12	data	data	NOUN
chd-200	48	13	extraction	extraction	NOUN
chd-200	48	14	,	,	PUNCT
chd-200	48	15	age	age	NOUN
chd-200	48	16	at	at	ADP
chd-200	48	17	cancer	cancer	NOUN
chd-200	48	18	diagnosis	diagnosis	NOUN
chd-200	48	19	,	,	PUNCT
chd-200	48	20	and	and	CCONJ
chd-200	48	21	sex	sex	NOUN
chd-200	48	22	at	at	ADP
chd-200	48	23	3:1	3:1	NUM
chd-200	48	24	,	,	PUNCT
chd-200	48	25	and	and	CCONJ
chd-200	48	26	the	the	DET
chd-200	48	27	ca-/covid+	ca-/covid+	NOUN
chd-200	48	28	group	group	NOUN
chd-200	48	29	was	be	AUX
chd-200	48	30	matched	match	VERB
chd-200	48	31	for	for	ADP
chd-200	48	32	age	age	NOUN
chd-200	48	33	at	at	ADP
chd-200	48	34	data	data	NOUN
chd-200	48	35	extraction	extraction	NOUN
chd-200	48	36	at	at	ADP
chd-200	48	37	3:1	3:1	NUM
chd-200	48	38	(	(	PUNCT
chd-200	48	39	figure	figure	NOUN
chd-200	48	40	1	1	NUM
chd-200	48	41	)	)	PUNCT
chd-200	48	42	.	.	PUNCT
chd-200	49	1	the	the	DET
chd-200	49	2	weighted	weight	VERB
chd-200	49	3	elixhauser	elixhauser	NOUN
chd-200	49	4	-	-	PUNCT
chd-200	49	5	comorbidity	comorbidity	NOUN
chd-200	49	6	score	score	NOUN
chd-200	49	7	was	be	AUX
chd-200	49	8	used	use	VERB
chd-200	49	9	to	to	PART
chd-200	49	10	quantify	quantify	VERB
chd-200	49	11	the	the	DET
chd-200	49	12	rate	rate	NOUN
chd-200	49	13	of	of	ADP
chd-200	49	14	comorbid	comorbid	ADJ
chd-200	49	15	medical	medical	ADJ
chd-200	49	16	conditions	condition	NOUN
chd-200	49	17	present	present	ADJ
chd-200	49	18	in	in	ADP
chd-200	49	19	each	each	DET
chd-200	49	20	group10,11	group10,11	NOUN
chd-200	49	21	.	.	PUNCT
chd-200	50	1	descriptive	descriptive	ADJ
chd-200	50	2	statistics	statistic	NOUN
chd-200	50	3	were	be	AUX
chd-200	50	4	generated	generate	VERB
chd-200	50	5	using	use	VERB
chd-200	50	6	r	r	NOUN
chd-200	50	7	software	software	NOUN
chd-200	50	8	(	(	PUNCT
chd-200	50	9	version	version	NOUN
chd-200	50	10	3.6.3	3.6.3	NUM
chd-200	50	11	)	)	PUNCT
chd-200	50	12	to	to	PART
chd-200	50	13	assess	assess	VERB
chd-200	50	14	demographic	demographic	ADJ
chd-200	50	15	and	and	CCONJ
chd-200	50	16	treatment	treatment	NOUN
chd-200	50	17	differences	difference	NOUN
chd-200	50	18	between	between	ADP
chd-200	50	19	cases	case	NOUN
chd-200	50	20	and	and	CCONJ
chd-200	50	21	each	each	DET
chd-200	50	22	control	control	NOUN
chd-200	50	23	group	group	NOUN
chd-200	50	24	.	.	PUNCT
chd-200	51	1	t	t	NOUN
chd-200	51	2	-	-	PUNCT
chd-200	51	3	tests	test	NOUN
chd-200	51	4	were	be	AUX
chd-200	51	5	performed	perform	VERB
chd-200	51	6	to	to	PART
chd-200	51	7	compare	compare	VERB
chd-200	51	8	differences	difference	NOUN
chd-200	51	9	in	in	ADP
chd-200	51	10	mean	mean	ADJ
chd-200	51	11	and	and	CCONJ
chd-200	51	12	chi	chi	ADJ
chd-200	51	13	-	-	PUNCT
chd-200	51	14	square	square	ADJ
chd-200	51	15	tests	test	NOUN
chd-200	51	16	assess	assess	VERB
chd-200	51	17	differences	difference	NOUN
chd-200	51	18	in	in	ADP
chd-200	51	19	proportion	proportion	NOUN
chd-200	51	20	.	.	PUNCT
chd-200	52	1	a	a	DET
chd-200	52	2	p	p	X
chd-200	52	3	<	<	X
chd-200	52	4	0.05	0.05	NUM
chd-200	52	5	was	be	AUX
chd-200	52	6	considered	consider	VERB
chd-200	52	7	statistically	statistically	ADV
chd-200	52	8	significant	significant	ADJ
chd-200	52	9	.	.	PUNCT
chd-200	53	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-200	53	2	e3	e3	NOUN
chd-200	53	3	cancer	cancer	NOUN
chd-200	53	4	health	health	NOUN
chd-200	53	5	disparities	disparity	NOUN
chd-200	53	6	research	research	NOUN
chd-200	53	7	figure	figure	NOUN
chd-200	53	8	1	1	NUM
chd-200	53	9	.	.	PUNCT
chd-200	54	1	flow	flow	NOUN
chd-200	54	2	diagram	diagram	NOUN
chd-200	54	3	of	of	ADP
chd-200	54	4	included	include	VERB
chd-200	54	5	patients	patient	NOUN
chd-200	54	6	a	a	DET
chd-200	54	7	total	total	NOUN
chd-200	54	8	of	of	ADP
chd-200	54	9	166	166	NUM
chd-200	54	10	cases	case	NOUN
chd-200	54	11	were	be	AUX
chd-200	54	12	identified	identify	VERB
chd-200	54	13	(	(	PUNCT
chd-200	54	14	table	table	NOUN
chd-200	54	15	1	1	NUM
chd-200	54	16	)	)	PUNCT
chd-200	54	17	.	.	PUNCT
chd-200	55	1	the	the	DET
chd-200	55	2	median	median	ADJ
chd-200	55	3	follow	follow	VERB
chd-200	55	4	-	-	PUNCT
chd-200	55	5	up	up	ADP
chd-200	55	6	time	time	NOUN
chd-200	55	7	was	be	AUX
chd-200	55	8	53	53	NUM
chd-200	55	9	days	day	NOUN
chd-200	55	10	from	from	ADP
chd-200	55	11	covid19	covid19	NOUN
chd-200	55	12	diagnosis	diagnosis	NOUN
chd-200	55	13	.	.	PUNCT
chd-200	56	1	distribution	distribution	NOUN
chd-200	56	2	of	of	ADP
chd-200	56	3	cancer	cancer	NOUN
chd-200	56	4	differed	differ	VERB
chd-200	56	5	between	between	ADP
chd-200	56	6	the	the	DET
chd-200	56	7	ca+/covid+	ca+/covid+	PROPN
chd-200	56	8	and	and	CCONJ
chd-200	56	9	ca+/covidgroups	ca+/covidgroup	NOUN
chd-200	56	10	(	(	PUNCT
chd-200	56	11	p=0.026	p=0.026	NOUN
chd-200	56	12	)	)	PUNCT
chd-200	56	13	,	,	PUNCT
chd-200	56	14	with	with	ADP
chd-200	56	15	a	a	DET
chd-200	56	16	notably	notably	ADV
chd-200	56	17	higher	high	ADJ
chd-200	56	18	proportion	proportion	NOUN
chd-200	56	19	of	of	ADP
chd-200	56	20	oral	oral	ADJ
chd-200	56	21	cavity	cavity	NOUN
chd-200	56	22	and	and	CCONJ
chd-200	56	23	pharynx	pharynx	NOUN
chd-200	56	24	cancers	cancer	NOUN
chd-200	56	25	in	in	ADP
chd-200	56	26	the	the	DET
chd-200	56	27	ca+/covid	ca+/covid	PROPN
chd-200	56	28	population	population	NOUN
chd-200	56	29	(	(	PUNCT
chd-200	56	30	0.6	0.6	NUM
chd-200	56	31	%	%	NOUN
chd-200	56	32	compared	compare	VERB
chd-200	56	33	to	to	ADP
chd-200	56	34	4.2	4.2	NUM
chd-200	56	35	%	%	NOUN
chd-200	56	36	,	,	PUNCT
chd-200	56	37	p=0.045	p=0.045	ADJ
chd-200	56	38	)	)	PUNCT
chd-200	56	39	.	.	PUNCT
chd-200	57	1	cancer	cancer	NOUN
chd-200	57	2	related	relate	VERB
chd-200	57	3	treatment	treatment	NOUN
chd-200	57	4	in	in	ADP
chd-200	57	5	ca+/covid+	ca+/covid+	PROPN
chd-200	57	6	patients	patient	NOUN
chd-200	57	7	was	be	AUX
chd-200	57	8	uncommon	uncommon	ADJ
chd-200	57	9	with	with	ADP
chd-200	57	10	7.2	7.2	NUM
chd-200	57	11	%	%	NOUN
chd-200	57	12	and	and	CCONJ
chd-200	57	13	0.6	0.6	NUM
chd-200	57	14	%	%	NOUN
chd-200	57	15	of	of	ADP
chd-200	57	16	patients	patient	NOUN
chd-200	57	17	receiving	receive	VERB
chd-200	57	18	chemotherapy	chemotherapy	NOUN
chd-200	57	19	or	or	CCONJ
chd-200	57	20	radiation	radiation	NOUN
chd-200	57	21	,	,	PUNCT
chd-200	57	22	respectively	respectively	ADV
chd-200	57	23	,	,	PUNCT
chd-200	57	24	within	within	ADP
chd-200	57	25	30	30	NUM
chd-200	57	26	days	day	NOUN
chd-200	57	27	of	of	ADP
chd-200	57	28	their	their	PRON
chd-200	57	29	covid19	covid19	NOUN
chd-200	57	30	diagnosis	diagnosis	NOUN
chd-200	57	31	.	.	PUNCT
chd-200	58	1	only	only	ADV
chd-200	58	2	4	4	NUM
chd-200	58	3	ca+/covid+	ca+/covid+	PROPN
chd-200	58	4	patients	patient	NOUN
chd-200	58	5	(	(	PUNCT
chd-200	58	6	2.4	2.4	NUM
chd-200	58	7	%	%	NOUN
chd-200	58	8	)	)	PUNCT
chd-200	58	9	had	have	VERB
chd-200	58	10	a	a	DET
chd-200	58	11	surgery	surgery	NOUN
chd-200	58	12	in	in	ADP
chd-200	58	13	the	the	DET
chd-200	58	14	year	year	NOUN
chd-200	58	15	prior	prior	ADV
chd-200	58	16	to	to	ADP
chd-200	58	17	their	their	PRON
chd-200	58	18	covid19	covid19	NOUN
chd-200	58	19	diagnosis	diagnosis	NOUN
chd-200	58	20	.	.	PUNCT
chd-200	59	1	significant	significant	ADJ
chd-200	59	2	racial	racial	ADJ
chd-200	59	3	differences	difference	NOUN
chd-200	59	4	were	be	AUX
chd-200	59	5	identified	identify	VERB
chd-200	59	6	between	between	ADP
chd-200	59	7	groups	group	NOUN
chd-200	59	8	.	.	PUNCT
chd-200	60	1	the	the	DET
chd-200	60	2	racial	racial	ADJ
chd-200	60	3	distribution	distribution	NOUN
chd-200	60	4	of	of	ADP
chd-200	60	5	patients	patient	NOUN
chd-200	60	6	in	in	ADP
chd-200	60	7	the	the	DET
chd-200	60	8	ca+/covidgroup	ca+/covidgroup	NOUN
chd-200	60	9	was	be	AUX
chd-200	60	10	8.6	8.6	NUM
chd-200	60	11	%	%	NOUN
chd-200	60	12	aa	aa	NOUN
chd-200	60	13	vs.	vs.	ADP
chd-200	60	14	76.9	76.9	NUM
chd-200	60	15	%	%	NOUN
chd-200	60	16	white	white	ADJ
chd-200	60	17	(	(	PUNCT
chd-200	60	18	table	table	NOUN
chd-200	60	19	1	1	NUM
chd-200	60	20	)	)	PUNCT
chd-200	60	21	.	.	PUNCT
chd-200	61	1	a	a	DET
chd-200	61	2	significantly	significantly	ADV
chd-200	61	3	higher	high	ADJ
chd-200	61	4	proportion	proportion	NOUN
chd-200	61	5	of	of	ADP
chd-200	61	6	aa	aa	NOUN
chd-200	61	7	,	,	PUNCT
chd-200	61	8	41.0	41.0	NUM
chd-200	61	9	%	%	NOUN
chd-200	61	10	,	,	PUNCT
chd-200	61	11	was	be	AUX
chd-200	61	12	noted	note	VERB
chd-200	61	13	in	in	ADP
chd-200	61	14	patients	patient	NOUN
chd-200	61	15	with	with	ADP
chd-200	61	16	cancer	cancer	NOUN
chd-200	61	17	and	and	CCONJ
chd-200	61	18	covid19	covid19	NOUN
chd-200	61	19	(	(	PUNCT
chd-200	61	20	p<0.001	p<0.001	PROPN
chd-200	61	21	)	)	PUNCT
chd-200	61	22	.	.	PUNCT
chd-200	62	1	in	in	ADP
chd-200	62	2	the	the	DET
chd-200	62	3	comparison	comparison	NOUN
chd-200	62	4	of	of	ADP
chd-200	62	5	ca+/covid+	ca+/covid+	PROPN
chd-200	62	6	to	to	PART
chd-200	62	7	ca-/covid+	ca-/covid+	VERB
chd-200	62	8	,	,	PUNCT
chd-200	62	9	the	the	DET
chd-200	62	10	proportion	proportion	NOUN
chd-200	62	11	of	of	ADP
chd-200	62	12	aa	aa	NOUN
chd-200	62	13	patients	patient	NOUN
chd-200	62	14	was	be	AUX
chd-200	62	15	greater	great	ADJ
chd-200	62	16	in	in	ADP
chd-200	62	17	the	the	DET
chd-200	62	18	non	non	ADJ
chd-200	62	19	-	-	ADJ
chd-200	62	20	oncologic	oncologic	ADJ
chd-200	62	21	population	population	NOUN
chd-200	62	22	(	(	PUNCT
chd-200	62	23	41.0	41.0	NUM
chd-200	62	24	%	%	NOUN
chd-200	62	25	vs.	vs.	ADP
chd-200	62	26	47.6	47.6	NUM
chd-200	62	27	%	%	NOUN
chd-200	62	28	,	,	PUNCT
chd-200	62	29	p=0.014	p=0.014	ADV
chd-200	62	30	)	)	PUNCT
chd-200	62	31	.	.	PUNCT
chd-200	63	1	measures	measure	NOUN
chd-200	63	2	associated	associate	VERB
chd-200	63	3	with	with	ADP
chd-200	63	4	covid19	covid19	NOUN
chd-200	63	5	severity	severity	NOUN
chd-200	63	6	were	be	AUX
chd-200	63	7	examined	examine	VERB
chd-200	63	8	.	.	PUNCT
chd-200	64	1	a	a	DET
chd-200	64	2	weighted	weight	VERB
chd-200	64	3	elixhauser	elixhauser	NOUN
chd-200	64	4	comorbidity	comorbidity	NOUN
chd-200	64	5	score	score	NOUN
chd-200	64	6	>	>	X
chd-200	64	7	5	5	NUM
chd-200	64	8	was	be	AUX
chd-200	64	9	present	present	ADJ
chd-200	64	10	in	in	ADP
chd-200	64	11	91.6	91.6	NUM
chd-200	64	12	%	%	NOUN
chd-200	64	13	of	of	ADP
chd-200	64	14	ca+/covid+	ca+/covid+	PROPN
chd-200	64	15	patients	patient	NOUN
chd-200	64	16	compared	compare	VERB
chd-200	64	17	to	to	ADP
chd-200	64	18	82.3	82.3	NUM
chd-200	64	19	%	%	NOUN
chd-200	64	20	(	(	PUNCT
chd-200	64	21	p=0.003	p=0.003	NOUN
chd-200	64	22	)	)	PUNCT
chd-200	64	23	of	of	ADP
chd-200	64	24	ca+/covidand	ca+/covidand	NOUN
chd-200	64	25	52.3	52.3	NUM
chd-200	64	26	%	%	NOUN
chd-200	64	27	(	(	PUNCT
chd-200	64	28	p<0.001	p<0.001	PROPN
chd-200	64	29	)	)	PUNCT
chd-200	64	30	of	of	ADP
chd-200	64	31	ca-/covid+	ca-/covid+	ADJ
chd-200	64	32	patients	patient	NOUN
chd-200	64	33	.	.	PUNCT
chd-200	65	1	over	over	ADP
chd-200	65	2	1	1	NUM
chd-200	65	3	in	in	ADP
chd-200	65	4	5	5	NUM
chd-200	65	5	(	(	PUNCT
chd-200	65	6	22.3	22.3	NUM
chd-200	65	7	%	%	NOUN
chd-200	65	8	)	)	PUNCT
chd-200	65	9	of	of	ADP
chd-200	65	10	the	the	DET
chd-200	65	11	ca+/covid+	ca+/covid+	PROPN
chd-200	65	12	patients	patient	NOUN
chd-200	65	13	were	be	AUX
chd-200	65	14	admitted	admit	VERB
chd-200	65	15	to	to	ADP
chd-200	65	16	the	the	DET
chd-200	65	17	icu	icu	PROPN
chd-200	65	18	.	.	PUNCT
chd-200	66	1	this	this	PRON
chd-200	66	2	was	be	AUX
chd-200	66	3	not	not	PART
chd-200	66	4	significantly	significantly	ADV
chd-200	66	5	greater	great	ADJ
chd-200	66	6	than	than	ADP
chd-200	66	7	the	the	DET
chd-200	66	8	ca-/covid+	ca-/covid+	NOUN
chd-200	66	9	(	(	PUNCT
chd-200	66	10	16.3	16.3	NUM
chd-200	66	11	%	%	NOUN
chd-200	66	12	,	,	PUNCT
chd-200	66	13	p=	p=	NOUN
chd-200	66	14	0.101	0.101	NUM
chd-200	66	15	)	)	PUNCT
chd-200	66	16	.	.	PUNCT
chd-200	67	1	there	there	PRON
chd-200	67	2	was	be	VERB
chd-200	67	3	no	no	DET
chd-200	67	4	difference	difference	NOUN
chd-200	67	5	in	in	ADP
chd-200	67	6	ventilator	ventilator	NOUN
chd-200	67	7	use	use	NOUN
chd-200	67	8	(	(	PUNCT
chd-200	67	9	p=0.999	p=0.999	NOUN
chd-200	67	10	)	)	PUNCT
chd-200	67	11	.	.	PUNCT
chd-200	68	1	the	the	DET
chd-200	68	2	death	death	NOUN
chd-200	68	3	rate	rate	NOUN
chd-200	68	4	from	from	ADP
chd-200	68	5	covid19	covid19	NOUN
chd-200	68	6	was	be	AUX
chd-200	68	7	3.0	3.0	NUM
chd-200	68	8	%	%	NOUN
chd-200	68	9	in	in	ADP
chd-200	68	10	the	the	DET
chd-200	68	11	ca-/covid+	ca-/covid+	NOUN
chd-200	68	12	group	group	NOUN
chd-200	68	13	versus	versus	ADP
chd-200	68	14	4.8	4.8	NUM
chd-200	68	15	%	%	NOUN
chd-200	68	16	in	in	ADP
chd-200	68	17	the	the	DET
chd-200	68	18	ca+/covidgroup	ca+/covidgroup	NOUN
chd-200	68	19	,	,	PUNCT
chd-200	68	20	which	which	PRON
chd-200	68	21	was	be	AUX
chd-200	68	22	not	not	PART
chd-200	68	23	statistically	statistically	ADV
chd-200	68	24	significant	significant	ADJ
chd-200	68	25	(	(	PUNCT
chd-200	68	26	p=0.391	p=0.391	NOUN
chd-200	68	27	)	)	PUNCT
chd-200	68	28	.	.	PUNCT
chd-200	69	1	the	the	DET
chd-200	69	2	ca+/covid+	ca+/covid+	PROPN
chd-200	69	3	group	group	NOUN
chd-200	69	4	was	be	AUX
chd-200	69	5	further	far	ADV
chd-200	69	6	stratified	stratify	VERB
chd-200	69	7	by	by	ADP
chd-200	69	8	race	race	NOUN
chd-200	69	9	(	(	PUNCT
chd-200	69	10	table	table	NOUN
chd-200	69	11	2	2	NUM
chd-200	69	12	)	)	PUNCT
chd-200	69	13	.	.	PUNCT
chd-200	70	1	there	there	PRON
chd-200	70	2	was	be	VERB
chd-200	70	3	no	no	DET
chd-200	70	4	difference	difference	NOUN
chd-200	70	5	in	in	ADP
chd-200	70	6	types	type	NOUN
chd-200	70	7	of	of	ADP
chd-200	70	8	cancer	cancer	NOUN
chd-200	70	9	(	(	PUNCT
chd-200	70	10	p=0.394	p=0.394	NOUN
chd-200	70	11	)	)	PUNCT
chd-200	70	12	and	and	CCONJ
chd-200	70	13	comorbidity	comorbidity	NOUN
chd-200	70	14	score	score	NOUN
chd-200	70	15	by	by	ADP
chd-200	70	16	race	race	NOUN
chd-200	70	17	(	(	PUNCT
chd-200	70	18	p=.794	p=.794	NOUN
chd-200	70	19	)	)	PUNCT
chd-200	70	20	.	.	PUNCT
chd-200	71	1	outcomes	outcome	NOUN
chd-200	71	2	were	be	AUX
chd-200	71	3	equivalent	equivalent	ADJ
chd-200	71	4	between	between	ADP
chd-200	71	5	racial	racial	ADJ
chd-200	71	6	groups	group	NOUN
chd-200	71	7	in	in	ADP
chd-200	71	8	terms	term	NOUN
chd-200	71	9	of	of	ADP
chd-200	71	10	ventilator	ventilator	NOUN
chd-200	71	11	use	use	NOUN
chd-200	71	12	(	(	PUNCT
chd-200	71	13	94.7	94.7	NUM
chd-200	71	14	%	%	NOUN
chd-200	71	15	vs.	vs.	ADP
chd-200	71	16	95.6	95.6	NUM
chd-200	71	17	%	%	NOUN
chd-200	71	18	,	,	PUNCT
chd-200	71	19	p=0.999	p=0.999	NOUN
chd-200	71	20	)	)	PUNCT
chd-200	71	21	,	,	PUNCT
chd-200	71	22	icu	icu	PROPN
chd-200	71	23	admission	admission	NOUN
chd-200	71	24	(	(	PUNCT
chd-200	71	25	76.8	76.8	NUM
chd-200	71	26	%	%	NOUN
chd-200	71	27	vs.	vs.	ADP
chd-200	71	28	77.9	77.9	NUM
chd-200	71	29	%	%	NOUN
chd-200	71	30	,	,	PUNCT
chd-200	71	31	p=0.999	p=0.999	NOUN
chd-200	71	32	)	)	PUNCT
chd-200	71	33	,	,	PUNCT
chd-200	71	34	and	and	CCONJ
chd-200	71	35	death	death	NOUN
chd-200	71	36	(	(	PUNCT
chd-200	71	37	94.7	94.7	NUM
chd-200	71	38	%	%	NOUN
chd-200	71	39	vs.	vs.	ADP
chd-200	71	40	95.6	95.6	NUM
chd-200	71	41	%	%	NOUN
chd-200	71	42	,	,	PUNCT
chd-200	71	43	p=0.999	p=0.999	NOUN
chd-200	71	44	)	)	PUNCT
chd-200	71	45	.	.	PUNCT
chd-200	72	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-200	72	2	e4	e4	PROPN
chd-200	72	3	cancer	cancer	NOUN
chd-200	72	4	health	health	NOUN
chd-200	72	5	disparities	disparity	NOUN
chd-200	72	6	research	research	NOUN
chd-200	72	7	table	table	NOUN
chd-200	72	8	1	1	NUM
chd-200	72	9	.	.	PUNCT
chd-200	72	10	descriptive	descriptive	ADJ
chd-200	72	11	statistics	statistic	NOUN
chd-200	72	12	of	of	ADP
chd-200	72	13	patients	patient	NOUN
chd-200	72	14	diagnosed	diagnose	VERB
chd-200	72	15	with	with	ADP
chd-200	72	16	primary	primary	ADJ
chd-200	72	17	cancer	cancer	NOUN
chd-200	72	18	and	and	CCONJ
chd-200	72	19	covid19	covid19	NOUN
chd-200	72	20	with	with	ADP
chd-200	72	21	corresponding	correspond	VERB
chd-200	72	22	cancer	cancer	NOUN
chd-200	72	23	and	and	CCONJ
chd-200	72	24	covid19	covid19	NOUN
chd-200	72	25	controls	control	NOUN
chd-200	72	26	.	.	PUNCT
chd-200	73	1	patients	patient	NOUN
chd-200	73	2	with	with	ADP
chd-200	73	3	cancer	cancer	NOUN
chd-200	73	4	and	and	CCONJ
chd-200	73	5	covid19	covid19	NOUN
chd-200	73	6	(	(	PUNCT
chd-200	73	7	cancer+/covid+	cancer+/covid+	NOUN
chd-200	73	8	)	)	PUNCT
chd-200	73	9	patients	patient	NOUN
chd-200	73	10	with	with	ADP
chd-200	73	11	cancer	cancer	NOUN
chd-200	73	12	without	without	ADP
chd-200	73	13	covid19	covid19	NOUN
chd-200	73	14	(	(	PUNCT
chd-200	73	15	cancer+/covid-	cancer+/covid-	PROPN
chd-200	73	16	)	)	PUNCT
chd-200	74	1	p	p	X
chd-200	74	2	*	*	PUNCT
chd-200	74	3	patients	patient	NOUN
chd-200	74	4	with	with	ADP
chd-200	74	5	cancer	cancer	NOUN
chd-200	74	6	without	without	ADP
chd-200	74	7	covid19	covid19	NOUN
chd-200	74	8	(	(	PUNCT
chd-200	74	9	cancer-/covid+	cancer-/covid+	PROPN
chd-200	74	10	)	)	PUNCT
chd-200	75	1	p	p	X
chd-200	75	2	*	*	PUNCT
chd-200	75	3	overall	overall	ADJ
chd-200	75	4	n	n	PROPN
chd-200	75	5	166	166	NUM
chd-200	75	6	498	498	NUM
chd-200	75	7	498	498	NUM
chd-200	75	8	age	age	NOUN
chd-200	75	9	at	at	ADP
chd-200	75	10	cancer	cancer	NOUN
chd-200	75	11	diagnosis	diagnosis	NOUN
chd-200	75	12	,	,	PUNCT
chd-200	75	13	mean	mean	INTJ
chd-200	75	14	(	(	PUNCT
chd-200	75	15	sd)[range	sd)[range	NOUN
chd-200	75	16	]	]	X
chd-200	75	17	63.5	63.5	NUM
chd-200	75	18	(	(	PUNCT
chd-200	75	19	15.0	15.0	NUM
chd-200	75	20	)	)	PUNCT
chd-200	76	1	[	[	X
chd-200	76	2	19	19	NUM
chd-200	76	3	-	-	SYM
chd-200	76	4	91	91	NUM
chd-200	76	5	]	]	PUNCT
chd-200	76	6	63.5	63.5	NUM
chd-200	76	7	(	(	PUNCT
chd-200	76	8	15.0	15.0	NUM
chd-200	76	9	)	)	PUNCT
chd-200	77	1	[	[	X
chd-200	77	2	19	19	NUM
chd-200	77	3	-	-	SYM
chd-200	77	4	91	91	NUM
chd-200	77	5	]	]	SYM
chd-200	77	6	0.99	0.99	NUM
chd-200	77	7	--	--	PUNCT
chd-200	77	8	age	age	NOUN
chd-200	77	9	at	at	ADP
chd-200	77	10	covid	covid	PROPN
chd-200	77	11	diagnosis	diagnosis	NOUN
chd-200	77	12	,	,	PUNCT
chd-200	77	13	mean	mean	VERB
chd-200	77	14	(	(	PUNCT
chd-200	77	15	sd)[range	sd)[range	NOUN
chd-200	77	16	]	]	X
chd-200	77	17	68.2	68.2	NUM
chd-200	77	18	(	(	PUNCT
chd-200	77	19	15.1	15.1	NUM
chd-200	77	20	)	)	PUNCT
chd-200	78	1	[	[	X
chd-200	78	2	26	26	NUM
chd-200	78	3	-	-	SYM
chd-200	78	4	97	97	NUM
chd-200	78	5	]	]	SYM
chd-200	78	6	--68.2	--68.2	PUNCT
chd-200	78	7	(	(	PUNCT
chd-200	78	8	15.1	15.1	NUM
chd-200	78	9	)	)	PUNCT
chd-200	79	1	[	[	X
chd-200	79	2	26	26	NUM
chd-200	79	3	-	-	SYM
chd-200	79	4	97	97	NUM
chd-200	79	5	]	]	SYM
chd-200	79	6	0.86	0.86	NUM
chd-200	79	7	gender	gender	NOUN
chd-200	79	8	,	,	PUNCT
chd-200	79	9	n	n	CCONJ
chd-200	79	10	(	(	PUNCT
chd-200	79	11	%	%	INTJ
chd-200	79	12	)	)	PUNCT
chd-200	79	13	female	female	NOUN
chd-200	79	14	97	97	NUM
chd-200	79	15	(	(	PUNCT
chd-200	79	16	58.4	58.4	NUM
chd-200	79	17	%	%	NOUN
chd-200	79	18	)	)	PUNCT
chd-200	79	19	291	291	NUM
chd-200	79	20	(	(	PUNCT
chd-200	79	21	58.4	58.4	NUM
chd-200	79	22	%	%	NOUN
chd-200	79	23	)	)	PUNCT
chd-200	79	24	0.999	0.999	NUM
chd-200	79	25	303	303	NUM
chd-200	79	26	(	(	PUNCT
chd-200	79	27	60.8	60.8	NUM
chd-200	79	28	%	%	NOUN
chd-200	79	29	)	)	PUNCT
chd-200	79	30	0.647	0.647	NUM
chd-200	79	31	male	male	NOUN
chd-200	79	32	69	69	NUM
chd-200	79	33	(	(	PUNCT
chd-200	79	34	41.6	41.6	NUM
chd-200	79	35	%	%	NOUN
chd-200	79	36	)	)	PUNCT
chd-200	79	37	207	207	NUM
chd-200	79	38	(	(	PUNCT
chd-200	79	39	41.6	41.6	NUM
chd-200	79	40	%	%	NOUN
chd-200	79	41	)	)	PUNCT
chd-200	79	42	195	195	NUM
chd-200	79	43	(	(	PUNCT
chd-200	79	44	39.2	39.2	NUM
chd-200	79	45	%	%	NOUN
chd-200	79	46	)	)	PUNCT
chd-200	79	47	race	race	NOUN
chd-200	79	48	,	,	PUNCT
chd-200	79	49	n	n	CCONJ
chd-200	79	50	(	(	PUNCT
chd-200	79	51	%	%	INTJ
chd-200	79	52	)	)	PUNCT
chd-200	79	53	white	white	PROPN
chd-200	79	54	95	95	NUM
chd-200	79	55	(	(	PUNCT
chd-200	79	56	57.2	57.2	NUM
chd-200	79	57	%	%	NOUN
chd-200	79	58	)	)	PUNCT
chd-200	79	59	383	383	NUM
chd-200	79	60	(	(	PUNCT
chd-200	79	61	76.9	76.9	NUM
chd-200	79	62	%	%	NOUN
chd-200	79	63	)	)	PUNCT
chd-200	80	1	<	<	X
chd-200	80	2	0.001	0.001	NUM
chd-200	80	3	218	218	NUM
chd-200	80	4	(	(	PUNCT
chd-200	80	5	43.8	43.8	NUM
chd-200	80	6	%	%	NOUN
chd-200	80	7	)	)	PUNCT
chd-200	80	8	0.014	0.014	NUM
chd-200	80	9	african	african	ADJ
chd-200	80	10	american	american	PROPN
chd-200	80	11	68	68	NUM
chd-200	80	12	(	(	PUNCT
chd-200	80	13	41.0	41.0	NUM
chd-200	80	14	%	%	NOUN
chd-200	80	15	)	)	PUNCT
chd-200	80	16	43	43	NUM
chd-200	80	17	(	(	PUNCT
chd-200	80	18	8.6	8.6	NUM
chd-200	80	19	%	%	NOUN
chd-200	80	20	)	)	PUNCT
chd-200	80	21	237	237	NUM
chd-200	80	22	(	(	PUNCT
chd-200	80	23	47.6	47.6	NUM
chd-200	80	24	%	%	NOUN
chd-200	80	25	)	)	PUNCT
chd-200	80	26	other	other	ADJ
chd-200	80	27	2	2	NUM
chd-200	80	28	(	(	PUNCT
chd-200	80	29	1.2	1.2	NUM
chd-200	80	30	%	%	NOUN
chd-200	80	31	)	)	PUNCT
chd-200	80	32	39	39	NUM
chd-200	80	33	(	(	PUNCT
chd-200	80	34	7.8	7.8	NUM
chd-200	80	35	%	%	NOUN
chd-200	80	36	)	)	PUNCT
chd-200	80	37	20	20	NUM
chd-200	80	38	(	(	PUNCT
chd-200	80	39	4.0	4.0	NUM
chd-200	80	40	%	%	NOUN
chd-200	80	41	)	)	PUNCT
chd-200	80	42	unknown	unknown	ADJ
chd-200	80	43	1	1	NUM
chd-200	80	44	(	(	PUNCT
chd-200	80	45	0.6	0.6	NUM
chd-200	80	46	%	%	NOUN
chd-200	80	47	)	)	PUNCT
chd-200	80	48	33	33	NUM
chd-200	80	49	(	(	PUNCT
chd-200	80	50	6.6	6.6	NUM
chd-200	80	51	%	%	NOUN
chd-200	80	52	)	)	PUNCT
chd-200	80	53	23	23	NUM
chd-200	80	54	(	(	PUNCT
chd-200	80	55	4.6	4.6	NUM
chd-200	80	56	%	%	NOUN
chd-200	80	57	)	)	PUNCT
chd-200	80	58	ethnicity	ethnicity	NOUN
chd-200	80	59	,	,	PUNCT
chd-200	80	60	n	n	CCONJ
chd-200	80	61	(	(	PUNCT
chd-200	80	62	%	%	INTJ
chd-200	80	63	)	)	PUNCT
chd-200	80	64	hispanic	hispanic	ADJ
chd-200	80	65	2	2	NUM
chd-200	80	66	(	(	PUNCT
chd-200	80	67	1.2	1.2	NUM
chd-200	80	68	%	%	NOUN
chd-200	80	69	)	)	PUNCT
chd-200	80	70	5	5	NUM
chd-200	80	71	(	(	PUNCT
chd-200	80	72	1.0	1.0	NUM
chd-200	80	73	%	%	NOUN
chd-200	80	74	)	)	PUNCT
chd-200	81	1	0.999	0.999	NUM
chd-200	81	2	0	0	NUM
chd-200	81	3	(	(	PUNCT
chd-200	81	4	0.0	0.0	NUM
chd-200	81	5	%	%	NOUN
chd-200	81	6	)	)	PUNCT
chd-200	81	7	0.137	0.137	NUM
chd-200	81	8	non	non	ADJ
chd-200	81	9	-	-	ADJ
chd-200	81	10	hispanic	hispanic	ADJ
chd-200	81	11	160	160	NUM
chd-200	81	12	(	(	PUNCT
chd-200	81	13	96.4	96.4	NUM
chd-200	81	14	%	%	NOUN
chd-200	81	15	)	)	PUNCT
chd-200	81	16	453	453	NUM
chd-200	81	17	(	(	PUNCT
chd-200	81	18	91.0	91.0	NUM
chd-200	81	19	%	%	NOUN
chd-200	81	20	)	)	PUNCT
chd-200	81	21	418	418	NUM
chd-200	81	22	(	(	PUNCT
chd-200	81	23	83.9	83.9	NUM
chd-200	81	24	%	%	NOUN
chd-200	81	25	)	)	PUNCT
chd-200	81	26	unknown	unknown	ADJ
chd-200	81	27	4	4	NUM
chd-200	81	28	(	(	PUNCT
chd-200	81	29	2.4	2.4	NUM
chd-200	81	30	%	%	NOUN
chd-200	81	31	)	)	PUNCT
chd-200	81	32	40	40	NUM
chd-200	81	33	(	(	PUNCT
chd-200	81	34	8.0	8.0	NUM
chd-200	81	35	%	%	NOUN
chd-200	81	36	)	)	PUNCT
chd-200	81	37	80	80	NUM
chd-200	81	38	(	(	PUNCT
chd-200	81	39	16.1	16.1	NUM
chd-200	81	40	%	%	NOUN
chd-200	81	41	)	)	PUNCT
chd-200	81	42	first	first	ADJ
chd-200	81	43	cancer	cancer	NOUN
chd-200	81	44	,	,	PUNCT
chd-200	81	45	n	n	PROPN
chd-200	81	46	(	(	PUNCT
chd-200	81	47	%	%	INTJ
chd-200	81	48	)	)	PUNCT
chd-200	81	49	bones	bone	NOUN
chd-200	81	50	and	and	CCONJ
chd-200	81	51	joints	joint	NOUN
chd-200	81	52	3	3	NUM
chd-200	81	53	(	(	PUNCT
chd-200	81	54	1.8	1.8	NUM
chd-200	81	55	%	%	NOUN
chd-200	81	56	)	)	PUNCT
chd-200	81	57	6	6	NUM
chd-200	81	58	(	(	PUNCT
chd-200	81	59	1.2	1.2	NUM
chd-200	81	60	%	%	NOUN
chd-200	81	61	)	)	PUNCT
chd-200	81	62	0.026	0.026	NUM
chd-200	81	63	--	--	PUNCT
chd-200	81	64	brain	brain	NOUN
chd-200	81	65	and	and	CCONJ
chd-200	81	66	other	other	ADJ
chd-200	81	67	nervous	nervous	ADJ
chd-200	81	68	system	system	NOUN
chd-200	81	69	3	3	NUM
chd-200	81	70	(	(	PUNCT
chd-200	81	71	1.8	1.8	NUM
chd-200	81	72	%	%	NOUN
chd-200	81	73	)	)	PUNCT
chd-200	81	74	19	19	NUM
chd-200	81	75	(	(	PUNCT
chd-200	81	76	3.8	3.8	NUM
chd-200	81	77	%	%	NOUN
chd-200	81	78	)	)	PUNCT
chd-200	81	79	-	-	PUNCT
chd-200	81	80	breast	breast	NOUN
chd-200	81	81	31	31	NUM
chd-200	81	82	(	(	PUNCT
chd-200	81	83	18.7	18.7	NUM
chd-200	81	84	%	%	NOUN
chd-200	81	85	)	)	PUNCT
chd-200	81	86	96	96	NUM
chd-200	81	87	(	(	PUNCT
chd-200	81	88	19.3	19.3	NUM
chd-200	81	89	%	%	NOUN
chd-200	81	90	)	)	PUNCT
chd-200	81	91	-	-	PUNCT
chd-200	81	92	digestive	digestive	ADJ
chd-200	81	93	system	system	NOUN
chd-200	81	94	20	20	NUM
chd-200	81	95	(	(	PUNCT
chd-200	81	96	12.0	12.0	NUM
chd-200	81	97	%	%	NOUN
chd-200	81	98	)	)	PUNCT
chd-200	81	99	92	92	NUM
chd-200	81	100	(	(	PUNCT
chd-200	81	101	18.5	18.5	NUM
chd-200	81	102	%	%	NOUN
chd-200	81	103	)	)	PUNCT
chd-200	81	104	-	-	PUNCT
chd-200	81	105	endocrine	endocrine	NOUN
chd-200	81	106	system	system	NOUN
chd-200	81	107	8	8	NUM
chd-200	81	108	(	(	PUNCT
chd-200	81	109	4.8	4.8	NUM
chd-200	81	110	%	%	NOUN
chd-200	81	111	)	)	PUNCT
chd-200	81	112	11	11	NUM
chd-200	81	113	(	(	PUNCT
chd-200	81	114	2.2	2.2	NUM
chd-200	81	115	%	%	NOUN
chd-200	81	116	)	)	PUNCT
chd-200	81	117	-	-	PUNCT
chd-200	81	118	female	female	ADJ
chd-200	81	119	genital	genital	ADJ
chd-200	81	120	system	system	NOUN
chd-200	81	121	11	11	NUM
chd-200	81	122	(	(	PUNCT
chd-200	81	123	6.6	6.6	NUM
chd-200	81	124	%	%	NOUN
chd-200	81	125	)	)	PUNCT
chd-200	81	126	30	30	NUM
chd-200	81	127	(	(	PUNCT
chd-200	81	128	6.0	6.0	NUM
chd-200	81	129	%	%	NOUN
chd-200	81	130	)	)	PUNCT
chd-200	81	131	-	-	PUNCT
chd-200	81	132	leukemia	leukemia	NOUN
chd-200	81	133	10	10	NUM
chd-200	81	134	(	(	PUNCT
chd-200	81	135	6.0	6.0	NUM
chd-200	81	136	%	%	NOUN
chd-200	81	137	)	)	PUNCT
chd-200	81	138	18	18	NUM
chd-200	81	139	(	(	PUNCT
chd-200	81	140	3.6	3.6	NUM
chd-200	81	141	%	%	NOUN
chd-200	81	142	)	)	PUNCT
chd-200	81	143	-	-	PUNCT
chd-200	81	144	lymphoma	lymphoma	NOUN
chd-200	81	145	8	8	NUM
chd-200	81	146	(	(	PUNCT
chd-200	81	147	4.8	4.8	NUM
chd-200	81	148	%	%	NOUN
chd-200	81	149	)	)	PUNCT
chd-200	81	150	18	18	NUM
chd-200	81	151	(	(	PUNCT
chd-200	81	152	3.6	3.6	NUM
chd-200	81	153	%	%	NOUN
chd-200	81	154	)	)	PUNCT
chd-200	81	155	-	-	PUNCT
chd-200	81	156	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	CCONJ
chd-200	81	157	e5	e5	PROPN
chd-200	81	158	cancer	cancer	NOUN
chd-200	81	159	health	health	NOUN
chd-200	81	160	disparities	disparity	NOUN
chd-200	81	161	research	research	VERB
chd-200	81	162	male	male	ADJ
chd-200	81	163	genital	genital	ADJ
chd-200	81	164	system	system	NOUN
chd-200	81	165	22	22	NUM
chd-200	81	166	(	(	PUNCT
chd-200	81	167	13.3	13.3	NUM
chd-200	81	168	%	%	NOUN
chd-200	81	169	)	)	PUNCT
chd-200	81	170	52	52	NUM
chd-200	81	171	(	(	PUNCT
chd-200	81	172	10.4	10.4	NUM
chd-200	81	173	%	%	NOUN
chd-200	81	174	)	)	PUNCT
chd-200	81	175	-	-	PUNCT
chd-200	81	176	oral	oral	ADJ
chd-200	81	177	cavity	cavity	NOUN
chd-200	81	178	and	and	CCONJ
chd-200	81	179	pharynx	pharynx	NOUN
chd-200	81	180	1	1	NUM
chd-200	81	181	(	(	PUNCT
chd-200	81	182	0.6	0.6	NUM
chd-200	81	183	%	%	NOUN
chd-200	81	184	)	)	PUNCT
chd-200	81	185	21	21	NUM
chd-200	81	186	(	(	PUNCT
chd-200	81	187	4.2	4.2	NUM
chd-200	81	188	%	%	NOUN
chd-200	81	189	)	)	PUNCT
chd-200	81	190	-	-	PUNCT
chd-200	81	191	respiratory	respiratory	ADJ
chd-200	81	192	system	system	NOUN
chd-200	81	193	14	14	NUM
chd-200	81	194	(	(	PUNCT
chd-200	81	195	8.4	8.4	NUM
chd-200	81	196	%	%	NOUN
chd-200	81	197	)	)	PUNCT
chd-200	81	198	39	39	NUM
chd-200	81	199	(	(	PUNCT
chd-200	81	200	7.8	7.8	NUM
chd-200	81	201	%	%	NOUN
chd-200	81	202	)	)	PUNCT
chd-200	81	203	-	-	PUNCT
chd-200	81	204	skin	skin	NOUN
chd-200	81	205	5	5	NUM
chd-200	81	206	(	(	PUNCT
chd-200	81	207	3.0	3.0	NUM
chd-200	81	208	%	%	NOUN
chd-200	81	209	)	)	PUNCT
chd-200	81	210	39	39	NUM
chd-200	81	211	(	(	PUNCT
chd-200	81	212	7.8	7.8	NUM
chd-200	81	213	%	%	NOUN
chd-200	81	214	)	)	PUNCT
chd-200	81	215	-	-	PUNCT
chd-200	81	216	urinary	urinary	ADJ
chd-200	81	217	system	system	NOUN
chd-200	81	218	11	11	NUM
chd-200	81	219	(	(	PUNCT
chd-200	81	220	6.6	6.6	NUM
chd-200	81	221	%	%	NOUN
chd-200	81	222	)	)	PUNCT
chd-200	81	223	20	20	NUM
chd-200	81	224	(	(	PUNCT
chd-200	81	225	4.0	4.0	NUM
chd-200	81	226	%	%	NOUN
chd-200	81	227	)	)	PUNCT
chd-200	81	228	-	-	PUNCT
chd-200	81	229	other	other	ADJ
chd-200	81	230	/	/	SYM
chd-200	81	231	unspecified	unspecified	ADJ
chd-200	81	232	19	19	NUM
chd-200	81	233	(	(	PUNCT
chd-200	81	234	11.4	11.4	NUM
chd-200	81	235	%	%	NOUN
chd-200	81	236	)	)	PUNCT
chd-200	81	237	37	37	NUM
chd-200	81	238	(	(	PUNCT
chd-200	81	239	7.4	7.4	NUM
chd-200	81	240	%	%	NOUN
chd-200	81	241	)	)	PUNCT
chd-200	81	242	-	-	PUNCT
chd-200	81	243	weighted	weight	VERB
chd-200	81	244	elixhauser	elixhauser	PROPN
chd-200	81	245	comorbidity	comorbidity	NOUN
chd-200	81	246	score	score	NOUN
chd-200	81	247	,	,	PUNCT
chd-200	81	248	n	n	PROPN
chd-200	81	249	(	(	PUNCT
chd-200	81	250	%	%	INTJ
chd-200	81	251	)	)	PUNCT
chd-200	82	1	<	<	X
chd-200	82	2	0	0	NUM
chd-200	82	3	3	3	NUM
chd-200	82	4	(	(	PUNCT
chd-200	82	5	1.8	1.8	NUM
chd-200	82	6	%	%	NOUN
chd-200	82	7	)	)	PUNCT
chd-200	82	8	16	16	NUM
chd-200	82	9	(	(	PUNCT
chd-200	82	10	3.2	3.2	NUM
chd-200	82	11	%	%	NOUN
chd-200	82	12	)	)	PUNCT
chd-200	82	13	0.003	0.003	NUM
chd-200	82	14	122	122	NUM
chd-200	82	15	(	(	PUNCT
chd-200	82	16	26.2	26.2	NUM
chd-200	82	17	%	%	NOUN
chd-200	82	18	)	)	PUNCT
chd-200	82	19	<	<	X
chd-200	82	20	0.001	0.001	NUM
chd-200	82	21	0	0	NUM
chd-200	82	22	2	2	NUM
chd-200	82	23	(	(	PUNCT
chd-200	82	24	1.2	1.2	NUM
chd-200	82	25	%	%	NOUN
chd-200	82	26	)	)	PUNCT
chd-200	82	27	48	48	NUM
chd-200	82	28	(	(	PUNCT
chd-200	82	29	9.6	9.6	NUM
chd-200	82	30	%	%	NOUN
chd-200	82	31	)	)	PUNCT
chd-200	82	32	60	60	NUM
chd-200	82	33	(	(	PUNCT
chd-200	82	34	12.9	12.9	NUM
chd-200	82	35	%	%	NOUN
chd-200	82	36	)	)	PUNCT
chd-200	82	37	1	1	NUM
chd-200	82	38	-	-	SYM
chd-200	82	39	4	4	NUM
chd-200	82	40	9	9	NUM
chd-200	82	41	(	(	PUNCT
chd-200	82	42	5.4	5.4	NUM
chd-200	82	43	%	%	NOUN
chd-200	82	44	)	)	PUNCT
chd-200	82	45	24	24	NUM
chd-200	82	46	(	(	PUNCT
chd-200	82	47	4.8	4.8	NUM
chd-200	82	48	%	%	NOUN
chd-200	82	49	)	)	PUNCT
chd-200	82	50	40	40	NUM
chd-200	82	51	(	(	PUNCT
chd-200	82	52	8.6	8.6	NUM
chd-200	82	53	%	%	NOUN
chd-200	82	54	)	)	PUNCT
chd-200	82	55	>	>	PUNCT
chd-200	83	1	=	=	SYM
chd-200	83	2	5	5	NUM
chd-200	83	3	152	152	NUM
chd-200	83	4	(	(	PUNCT
chd-200	83	5	91.6	91.6	NUM
chd-200	83	6	%	%	NOUN
chd-200	83	7	)	)	PUNCT
chd-200	83	8	410	410	NUM
chd-200	83	9	(	(	PUNCT
chd-200	83	10	82.3	82.3	NUM
chd-200	83	11	%	%	NOUN
chd-200	83	12	)	)	PUNCT
chd-200	83	13	243	243	NUM
chd-200	83	14	(	(	PUNCT
chd-200	83	15	52.3	52.3	NUM
chd-200	83	16	%	%	NOUN
chd-200	83	17	)	)	PUNCT
chd-200	83	18	ventilator	ventilator	NOUN
chd-200	83	19	use	use	NOUN
chd-200	83	20	,	,	PUNCT
chd-200	83	21	n	n	CCONJ
chd-200	83	22	(	(	PUNCT
chd-200	83	23	%	%	INTJ
chd-200	83	24	)	)	PUNCT
chd-200	83	25	no	no	DET
chd-200	83	26	158	158	NUM
chd-200	83	27	(	(	PUNCT
chd-200	83	28	95.2	95.2	NUM
chd-200	83	29	%	%	NOUN
chd-200	83	30	)	)	PUNCT
chd-200	83	31	--476	--476	CCONJ
chd-200	83	32	(	(	PUNCT
chd-200	83	33	95.6	95.6	NUM
chd-200	83	34	%	%	NOUN
chd-200	83	35	)	)	PUNCT
chd-200	84	1	0.999	0.999	NUM
chd-200	84	2	yes	yes	NOUN
chd-200	84	3	8	8	NUM
chd-200	84	4	(	(	PUNCT
chd-200	84	5	4.8	4.8	NUM
chd-200	84	6	%	%	NOUN
chd-200	84	7	)	)	PUNCT
chd-200	84	8	-	-	PUNCT
chd-200	84	9	22	22	NUM
chd-200	84	10	(	(	PUNCT
chd-200	84	11	4.4	4.4	NUM
chd-200	84	12	%	%	NOUN
chd-200	84	13	)	)	PUNCT
chd-200	84	14	admitted	admit	VERB
chd-200	84	15	to	to	ADP
chd-200	84	16	icu	icu	PROPN
chd-200	84	17	,	,	PUNCT
chd-200	84	18	n	n	CCONJ
chd-200	84	19	(	(	PUNCT
chd-200	84	20	%	%	INTJ
chd-200	84	21	)	)	PUNCT
chd-200	85	1	no	no	DET
chd-200	85	2	129	129	NUM
chd-200	85	3	(	(	PUNCT
chd-200	85	4	77.7	77.7	NUM
chd-200	85	5	%	%	NOUN
chd-200	85	6	)	)	PUNCT
chd-200	85	7	--417	--417	INTJ
chd-200	85	8	(	(	PUNCT
chd-200	85	9	83.7	83.7	NUM
chd-200	85	10	%	%	NOUN
chd-200	85	11	)	)	PUNCT
chd-200	86	1	0.101	0.101	NUM
chd-200	86	2	yes	yes	NUM
chd-200	86	3	37	37	NUM
chd-200	86	4	(	(	PUNCT
chd-200	86	5	22.3	22.3	NUM
chd-200	86	6	%	%	NOUN
chd-200	86	7	)	)	PUNCT
chd-200	86	8	-	-	PUNCT
chd-200	86	9	81	81	NUM
chd-200	86	10	(	(	PUNCT
chd-200	86	11	16.3	16.3	NUM
chd-200	86	12	%	%	NOUN
chd-200	86	13	)	)	PUNCT
chd-200	86	14	died	die	VERB
chd-200	86	15	within	within	ADP
chd-200	86	16	30	30	NUM
chd-200	86	17	days	day	NOUN
chd-200	86	18	of	of	ADP
chd-200	86	19	covid	covid	ADJ
chd-200	86	20	diagnosis	diagnosis	NOUN
chd-200	86	21	no	no	DET
chd-200	86	22	158	158	NUM
chd-200	86	23	(	(	PUNCT
chd-200	86	24	95.2	95.2	NUM
chd-200	86	25	%	%	NOUN
chd-200	86	26	)	)	PUNCT
chd-200	87	1	--483	--483	PROPN
chd-200	88	1	(	(	PUNCT
chd-200	88	2	97.0	97.0	NUM
chd-200	88	3	%	%	NOUN
chd-200	88	4	)	)	PUNCT
chd-200	88	5	0.391	0.391	NUM
chd-200	88	6	yes	yes	NOUN
chd-200	88	7	8	8	NUM
chd-200	88	8	(	(	PUNCT
chd-200	88	9	4.8	4.8	NUM
chd-200	88	10	%	%	NOUN
chd-200	88	11	)	)	PUNCT
chd-200	88	12	-	-	PUNCT
chd-200	88	13	15	15	NUM
chd-200	88	14	(	(	PUNCT
chd-200	88	15	3.0	3.0	NUM
chd-200	88	16	%	%	NOUN
chd-200	88	17	)	)	PUNCT
chd-200	89	1	*	*	PUNCT
chd-200	89	2	:	:	PUNCT
chd-200	89	3	p	p	PRON
chd-200	89	4	considered	consider	VERB
chd-200	89	5	significant	significant	ADJ
chd-200	89	6	if	if	SCONJ
chd-200	89	7	<	<	X
chd-200	89	8	0.05	0.05	NUM
chd-200	89	9	,	,	PUNCT
chd-200	89	10	sd	sd	NOUN
chd-200	89	11	:	:	PUNCT
chd-200	89	12	standard	standard	ADJ
chd-200	89	13	deviation	deviation	NOUN
chd-200	89	14	table	table	NOUN
chd-200	89	15	2	2	NUM
chd-200	89	16	.	.	PUNCT
chd-200	89	17	descriptive	descriptive	ADJ
chd-200	89	18	statistics	statistic	NOUN
chd-200	89	19	of	of	ADP
chd-200	89	20	cases	case	NOUN
chd-200	89	21	(	(	PUNCT
chd-200	89	22	cancer+/covid19	cancer+/covid19	NOUN
chd-200	89	23	+	+	NOUN
chd-200	89	24	)	)	PUNCT
chd-200	89	25	stratified	stratify	VERB
chd-200	89	26	by	by	ADP
chd-200	89	27	race	race	NOUN
chd-200	89	28	.	.	PUNCT
chd-200	90	1	study	study	NOUN
chd-200	90	2	population	population	NOUN
chd-200	90	3	(	(	PUNCT
chd-200	90	4	cancer+/covid19	cancer+/covid19	NOUN
chd-200	90	5	+	+	NOUN
chd-200	90	6	)	)	PUNCT
chd-200	90	7	white	white	ADJ
chd-200	90	8	black	black	NOUN
chd-200	90	9	p	p	X
chd-200	90	10	*	*	PUNCT
chd-200	90	11	overall	overall	ADJ
chd-200	90	12	n	n	ADV
chd-200	90	13	95	95	NUM
chd-200	90	14	68	68	NUM
chd-200	90	15	age	age	NOUN
chd-200	90	16	at	at	ADP
chd-200	90	17	cancer	cancer	NOUN
chd-200	90	18	diagnosis	diagnosis	NOUN
chd-200	90	19	,	,	PUNCT
chd-200	90	20	mean	mean	NOUN
chd-200	90	21	(	(	PUNCT
chd-200	90	22	sd	sd	NOUN
chd-200	90	23	)	)	PUNCT
chd-200	90	24	65.0	65.0	NUM
chd-200	90	25	(	(	PUNCT
chd-200	90	26	13.7	13.7	NUM
chd-200	90	27	)	)	PUNCT
chd-200	90	28	61.8	61.8	NUM
chd-200	90	29	(	(	PUNCT
chd-200	90	30	15.5	15.5	NUM
chd-200	90	31	)	)	PUNCT
chd-200	90	32	0.162	0.162	NUM
chd-200	90	33	age	age	NOUN
chd-200	90	34	at	at	ADP
chd-200	90	35	covid	covid	PROPN
chd-200	90	36	diagnosis	diagnosis	NOUN
chd-200	90	37	,	,	PUNCT
chd-200	90	38	mean	mean	NOUN
chd-200	90	39	(	(	PUNCT
chd-200	90	40	sd	sd	NOUN
chd-200	90	41	)	)	PUNCT
chd-200	90	42	69.4	69.4	NUM
chd-200	90	43	(	(	PUNCT
chd-200	90	44	14.3	14.3	NUM
chd-200	90	45	)	)	PUNCT
chd-200	90	46	66.8	66.8	NUM
chd-200	90	47	(	(	PUNCT
chd-200	90	48	15.6	15.6	NUM
chd-200	90	49	)	)	PUNCT
chd-200	90	50	0.276	0.276	NUM
chd-200	90	51	gender	gender	NOUN
chd-200	90	52	,	,	PUNCT
chd-200	90	53	n	n	CCONJ
chd-200	90	54	(	(	PUNCT
chd-200	90	55	%	%	INTJ
chd-200	90	56	)	)	PUNCT
chd-200	90	57	female	female	NOUN
chd-200	90	58	55	55	NUM
chd-200	90	59	(	(	PUNCT
chd-200	90	60	57.9	57.9	NUM
chd-200	90	61	%	%	NOUN
chd-200	90	62	)	)	PUNCT
chd-200	90	63	40	40	NUM
chd-200	90	64	(	(	PUNCT
chd-200	90	65	58.8	58.8	NUM
chd-200	90	66	%	%	NOUN
chd-200	90	67	)	)	PUNCT
chd-200	90	68	0.999	0.999	NUM
chd-200	90	69	male	male	NOUN
chd-200	90	70	40	40	NUM
chd-200	90	71	(	(	PUNCT
chd-200	90	72	42.1	42.1	NUM
chd-200	90	73	%	%	NOUN
chd-200	90	74	)	)	PUNCT
chd-200	90	75	28	28	NUM
chd-200	90	76	(	(	PUNCT
chd-200	90	77	41.2	41.2	NUM
chd-200	90	78	%	%	NOUN
chd-200	90	79	)	)	PUNCT
chd-200	90	80	ethnicity	ethnicity	NOUN
chd-200	90	81	,	,	PUNCT
chd-200	90	82	n	n	CCONJ
chd-200	90	83	(	(	PUNCT
chd-200	90	84	%	%	INTJ
chd-200	90	85	)	)	PUNCT
chd-200	90	86	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-200	90	87	e6	e6	VERB
chd-200	90	88	cancer	cancer	NOUN
chd-200	90	89	health	health	NOUN
chd-200	90	90	disparities	disparity	NOUN
chd-200	90	91	research	research	VERB
chd-200	90	92	hispanic	hispanic	NOUN
chd-200	90	93	2	2	NUM
chd-200	90	94	(	(	PUNCT
chd-200	90	95	2.2	2.2	NUM
chd-200	90	96	%	%	NOUN
chd-200	90	97	)	)	PUNCT
chd-200	90	98	0	0	NUM
chd-200	91	1	(	(	PUNCT
chd-200	91	2	0.0	0.0	NUM
chd-200	91	3	%	%	NOUN
chd-200	91	4	)	)	PUNCT
chd-200	91	5	0.609	0.609	NUM
chd-200	91	6	non	non	ADJ
chd-200	91	7	-	-	ADJ
chd-200	91	8	hispanic	hispanic	ADJ
chd-200	91	9	89	89	NUM
chd-200	91	10	(	(	PUNCT
chd-200	91	11	97.8	97.8	NUM
chd-200	91	12	%	%	NOUN
chd-200	91	13	)	)	PUNCT
chd-200	91	14	68	68	NUM
chd-200	91	15	(	(	PUNCT
chd-200	91	16	100.0	100.0	NUM
chd-200	91	17	%	%	NOUN
chd-200	91	18	)	)	PUNCT
chd-200	91	19	unknown	unknown	ADJ
chd-200	91	20	0	0	NUM
chd-200	91	21	(	(	PUNCT
chd-200	91	22	0.0	0.0	NUM
chd-200	91	23	%	%	NOUN
chd-200	91	24	)	)	PUNCT
chd-200	91	25	4	4	NUM
chd-200	91	26	(	(	PUNCT
chd-200	91	27	4.2	4.2	NUM
chd-200	91	28	%	%	NOUN
chd-200	91	29	)	)	PUNCT
chd-200	91	30	first	first	ADJ
chd-200	91	31	cancer	cancer	NOUN
chd-200	91	32	,	,	PUNCT
chd-200	91	33	n	n	PROPN
chd-200	91	34	(	(	PUNCT
chd-200	91	35	%	%	INTJ
chd-200	91	36	)	)	PUNCT
chd-200	91	37	bones	bone	NOUN
chd-200	91	38	and	and	CCONJ
chd-200	91	39	joints	joint	NOUN
chd-200	91	40	1	1	NUM
chd-200	91	41	(	(	PUNCT
chd-200	91	42	1.1	1.1	NUM
chd-200	91	43	%	%	NOUN
chd-200	91	44	)	)	PUNCT
chd-200	91	45	2	2	NUM
chd-200	91	46	(	(	PUNCT
chd-200	91	47	2.9	2.9	NUM
chd-200	91	48	%	%	NOUN
chd-200	91	49	)	)	PUNCT
chd-200	91	50	0.394	0.394	NUM
chd-200	91	51	brain	brain	NOUN
chd-200	91	52	and	and	CCONJ
chd-200	91	53	other	other	ADJ
chd-200	91	54	nervous	nervous	ADJ
chd-200	91	55	system	system	NOUN
chd-200	91	56	2	2	NUM
chd-200	91	57	(	(	PUNCT
chd-200	91	58	2.1	2.1	NUM
chd-200	91	59	%	%	NOUN
chd-200	91	60	)	)	PUNCT
chd-200	91	61	1	1	NUM
chd-200	91	62	(	(	PUNCT
chd-200	91	63	1.5	1.5	NUM
chd-200	91	64	%	%	NOUN
chd-200	91	65	)	)	PUNCT
chd-200	91	66	breast	breast	NOUN
chd-200	91	67	13	13	NUM
chd-200	91	68	(	(	PUNCT
chd-200	91	69	13.7	13.7	NUM
chd-200	91	70	%	%	NOUN
chd-200	91	71	)	)	PUNCT
chd-200	91	72	17	17	NUM
chd-200	91	73	(	(	PUNCT
chd-200	91	74	25.0	25.0	NUM
chd-200	91	75	%	%	NOUN
chd-200	91	76	)	)	PUNCT
chd-200	91	77	digestive	digestive	ADJ
chd-200	91	78	system	system	NOUN
chd-200	91	79	13	13	NUM
chd-200	91	80	(	(	PUNCT
chd-200	91	81	13.7	13.7	NUM
chd-200	91	82	%	%	NOUN
chd-200	91	83	)	)	PUNCT
chd-200	91	84	6	6	NUM
chd-200	91	85	(	(	PUNCT
chd-200	91	86	8.8	8.8	NUM
chd-200	91	87	%	%	NOUN
chd-200	91	88	)	)	PUNCT
chd-200	91	89	endocrine	endocrine	NOUN
chd-200	91	90	system	system	NOUN
chd-200	91	91	3	3	NUM
chd-200	91	92	(	(	PUNCT
chd-200	91	93	3.2	3.2	NUM
chd-200	91	94	%	%	NOUN
chd-200	91	95	)	)	PUNCT
chd-200	91	96	4	4	NUM
chd-200	91	97	(	(	PUNCT
chd-200	91	98	5.9	5.9	NUM
chd-200	91	99	%	%	NOUN
chd-200	91	100	)	)	PUNCT
chd-200	91	101	female	female	ADJ
chd-200	91	102	genital	genital	ADJ
chd-200	91	103	system	system	NOUN
chd-200	91	104	8	8	NUM
chd-200	91	105	(	(	PUNCT
chd-200	91	106	8.4	8.4	NUM
chd-200	91	107	%	%	NOUN
chd-200	91	108	)	)	PUNCT
chd-200	91	109	3	3	NUM
chd-200	91	110	(	(	PUNCT
chd-200	91	111	4.4	4.4	NUM
chd-200	91	112	%	%	NOUN
chd-200	91	113	)	)	PUNCT
chd-200	91	114	leukemia	leukemia	NOUN
chd-200	91	115	6	6	NUM
chd-200	91	116	(	(	PUNCT
chd-200	91	117	6.3	6.3	NUM
chd-200	91	118	%	%	NOUN
chd-200	91	119	)	)	PUNCT
chd-200	91	120	4	4	NUM
chd-200	91	121	(	(	PUNCT
chd-200	91	122	5.9	5.9	NUM
chd-200	91	123	%	%	NOUN
chd-200	91	124	)	)	PUNCT
chd-200	91	125	lymphoma	lymphoma	NOUN
chd-200	91	126	5	5	NUM
chd-200	91	127	(	(	PUNCT
chd-200	91	128	5.3	5.3	NUM
chd-200	91	129	%	%	NOUN
chd-200	91	130	)	)	PUNCT
chd-200	91	131	3	3	NUM
chd-200	91	132	(	(	PUNCT
chd-200	91	133	4.4	4.4	NUM
chd-200	91	134	%	%	NOUN
chd-200	91	135	)	)	PUNCT
chd-200	91	136	male	male	ADJ
chd-200	91	137	genital	genital	ADJ
chd-200	91	138	system	system	NOUN
chd-200	91	139	11	11	NUM
chd-200	91	140	(	(	PUNCT
chd-200	91	141	11.6	11.6	NUM
chd-200	91	142	%	%	NOUN
chd-200	91	143	)	)	PUNCT
chd-200	91	144	11	11	NUM
chd-200	91	145	(	(	PUNCT
chd-200	91	146	16.2	16.2	NUM
chd-200	91	147	%	%	NOUN
chd-200	91	148	)	)	PUNCT
chd-200	91	149	oral	oral	ADJ
chd-200	91	150	cavity	cavity	NOUN
chd-200	91	151	and	and	CCONJ
chd-200	91	152	pharynx	pharynx	NOUN
chd-200	91	153	1	1	NUM
chd-200	91	154	(	(	PUNCT
chd-200	91	155	1.1	1.1	NUM
chd-200	91	156	%	%	NOUN
chd-200	91	157	)	)	PUNCT
chd-200	91	158	0	0	NUM
chd-200	92	1	(	(	PUNCT
chd-200	92	2	0.0	0.0	NUM
chd-200	92	3	%	%	NOUN
chd-200	92	4	)	)	PUNCT
chd-200	92	5	respiratory	respiratory	ADJ
chd-200	92	6	system	system	NOUN
chd-200	92	7	10	10	NUM
chd-200	92	8	(	(	PUNCT
chd-200	92	9	10.5	10.5	NUM
chd-200	92	10	%	%	NOUN
chd-200	92	11	)	)	PUNCT
chd-200	92	12	9	9	NUM
chd-200	92	13	(	(	PUNCT
chd-200	92	14	13.2	13.2	NUM
chd-200	92	15	%	%	NOUN
chd-200	92	16	)	)	PUNCT
chd-200	92	17	skin	skin	NOUN
chd-200	92	18	11	11	NUM
chd-200	92	19	(	(	PUNCT
chd-200	92	20	11.6	11.6	NUM
chd-200	92	21	%	%	NOUN
chd-200	92	22	)	)	PUNCT
chd-200	92	23	3	3	NUM
chd-200	92	24	(	(	PUNCT
chd-200	92	25	4.4	4.4	NUM
chd-200	92	26	%	%	NOUN
chd-200	92	27	)	)	PUNCT
chd-200	92	28	urinary	urinary	ADJ
chd-200	92	29	system	system	NOUN
chd-200	92	30	5	5	NUM
chd-200	92	31	(	(	PUNCT
chd-200	92	32	5.3	5.3	NUM
chd-200	92	33	%	%	NOUN
chd-200	92	34	)	)	PUNCT
chd-200	92	35	0	0	NUM
chd-200	93	1	(	(	PUNCT
chd-200	93	2	0.0	0.0	NUM
chd-200	93	3	%	%	NOUN
chd-200	93	4	)	)	PUNCT
chd-200	93	5	other	other	ADJ
chd-200	93	6	/	/	SYM
chd-200	93	7	unspecified	unspecified	ADJ
chd-200	93	8	6	6	NUM
chd-200	93	9	(	(	PUNCT
chd-200	93	10	6.3	6.3	NUM
chd-200	93	11	%	%	NOUN
chd-200	93	12	)	)	PUNCT
chd-200	93	13	5	5	NUM
chd-200	93	14	(	(	PUNCT
chd-200	93	15	7.4	7.4	NUM
chd-200	93	16	%	%	NOUN
chd-200	93	17	)	)	PUNCT
chd-200	93	18	weighted	weight	VERB
chd-200	93	19	elixhauser	elixhauser	PROPN
chd-200	93	20	comorbidity	comorbidity	NOUN
chd-200	93	21	score	score	NOUN
chd-200	93	22	,	,	PUNCT
chd-200	93	23	n	n	PROPN
chd-200	93	24	(	(	PUNCT
chd-200	93	25	%	%	INTJ
chd-200	93	26	)	)	PUNCT
chd-200	94	1	<	<	X
chd-200	94	2	0	0	NUM
chd-200	94	3	2	2	NUM
chd-200	94	4	(	(	PUNCT
chd-200	94	5	2.1	2.1	NUM
chd-200	94	6	%	%	NOUN
chd-200	94	7	)	)	PUNCT
chd-200	94	8	1	1	NUM
chd-200	94	9	(	(	PUNCT
chd-200	94	10	1.5	1.5	NUM
chd-200	94	11	%	%	NOUN
chd-200	94	12	)	)	PUNCT
chd-200	94	13	0.794	0.794	NUM
chd-200	94	14	0	0	NUM
chd-200	94	15	1	1	NUM
chd-200	94	16	(	(	PUNCT
chd-200	94	17	1.1	1.1	NUM
chd-200	94	18	%	%	NOUN
chd-200	94	19	)	)	PUNCT
chd-200	94	20	0	0	NUM
chd-200	95	1	(	(	PUNCT
chd-200	95	2	0.0	0.0	NUM
chd-200	95	3	%	%	NOUN
chd-200	95	4	)	)	PUNCT
chd-200	95	5	1	1	NUM
chd-200	95	6	-	-	SYM
chd-200	95	7	4	4	NUM
chd-200	95	8	4	4	NUM
chd-200	95	9	(	(	PUNCT
chd-200	95	10	4.2	4.2	NUM
chd-200	95	11	%	%	NOUN
chd-200	95	12	)	)	PUNCT
chd-200	95	13	4	4	NUM
chd-200	95	14	(	(	PUNCT
chd-200	95	15	5.9	5.9	NUM
chd-200	95	16	%	%	NOUN
chd-200	95	17	)	)	PUNCT
chd-200	95	18	>	>	PUNCT
chd-200	96	1	=	=	SYM
chd-200	96	2	5	5	NUM
chd-200	96	3	88	88	NUM
chd-200	96	4	(	(	PUNCT
chd-200	96	5	92.6	92.6	NUM
chd-200	96	6	%	%	NOUN
chd-200	96	7	)	)	PUNCT
chd-200	96	8	63	63	NUM
chd-200	96	9	(	(	PUNCT
chd-200	96	10	92.6	92.6	NUM
chd-200	96	11	%	%	NOUN
chd-200	96	12	)	)	PUNCT
chd-200	96	13	ventilator	ventilator	NOUN
chd-200	96	14	use	use	NOUN
chd-200	96	15	,	,	PUNCT
chd-200	96	16	n	n	CCONJ
chd-200	96	17	(	(	PUNCT
chd-200	96	18	%	%	INTJ
chd-200	96	19	)	)	PUNCT
chd-200	97	1	no	no	DET
chd-200	97	2	90	90	NUM
chd-200	97	3	(	(	PUNCT
chd-200	97	4	94.7	94.7	NUM
chd-200	97	5	%	%	NOUN
chd-200	97	6	)	)	PUNCT
chd-200	97	7	65	65	NUM
chd-200	97	8	(	(	PUNCT
chd-200	97	9	95.6	95.6	NUM
chd-200	97	10	%	%	NOUN
chd-200	97	11	)	)	PUNCT
chd-200	98	1	0.999	0.999	NUM
chd-200	98	2	yes	yes	NUM
chd-200	98	3	5	5	NUM
chd-200	98	4	(	(	PUNCT
chd-200	98	5	5.3	5.3	NUM
chd-200	98	6	%	%	NOUN
chd-200	98	7	)	)	PUNCT
chd-200	98	8	3	3	NUM
chd-200	98	9	(	(	PUNCT
chd-200	98	10	4.4	4.4	NUM
chd-200	98	11	%	%	NOUN
chd-200	98	12	)	)	PUNCT
chd-200	98	13	admitted	admit	VERB
chd-200	98	14	to	to	ADP
chd-200	98	15	icu	icu	PROPN
chd-200	98	16	,	,	PUNCT
chd-200	98	17	n	n	CCONJ
chd-200	98	18	(	(	PUNCT
chd-200	98	19	%	%	INTJ
chd-200	98	20	)	)	PUNCT
chd-200	98	21	no	no	DET
chd-200	98	22	73	73	NUM
chd-200	98	23	(	(	PUNCT
chd-200	98	24	76.8	76.8	NUM
chd-200	98	25	%	%	NOUN
chd-200	98	26	)	)	PUNCT
chd-200	98	27	53	53	NUM
chd-200	98	28	(	(	PUNCT
chd-200	98	29	77.9	77.9	NUM
chd-200	98	30	%	%	NOUN
chd-200	98	31	)	)	PUNCT
chd-200	99	1	0.999	0.999	NUM
chd-200	99	2	yes	yes	NUM
chd-200	99	3	22	22	NUM
chd-200	99	4	(	(	PUNCT
chd-200	99	5	23.2	23.2	NUM
chd-200	99	6	%	%	NOUN
chd-200	99	7	)	)	PUNCT
chd-200	99	8	15	15	NUM
chd-200	99	9	(	(	PUNCT
chd-200	99	10	22.1	22.1	NUM
chd-200	99	11	%	%	NOUN
chd-200	99	12	)	)	PUNCT
chd-200	99	13	died	die	VERB
chd-200	99	14	within	within	ADP
chd-200	99	15	30	30	NUM
chd-200	99	16	days	day	NOUN
chd-200	99	17	of	of	ADP
chd-200	99	18	covid	covid	ADJ
chd-200	99	19	diagnosis	diagnosis	NOUN
chd-200	99	20	no	no	DET
chd-200	99	21	90	90	NUM
chd-200	99	22	(	(	PUNCT
chd-200	99	23	94.7	94.7	NUM
chd-200	99	24	%	%	NOUN
chd-200	99	25	)	)	PUNCT
chd-200	99	26	65	65	NUM
chd-200	99	27	(	(	PUNCT
chd-200	99	28	95.6	95.6	NUM
chd-200	99	29	%	%	NOUN
chd-200	99	30	)	)	PUNCT
chd-200	100	1	0.999	0.999	NUM
chd-200	100	2	yes	yes	NUM
chd-200	100	3	5	5	NUM
chd-200	100	4	(	(	PUNCT
chd-200	100	5	5.3	5.3	NUM
chd-200	100	6	%	%	NOUN
chd-200	100	7	)	)	PUNCT
chd-200	100	8	3	3	NUM
chd-200	100	9	(	(	PUNCT
chd-200	100	10	4.4	4.4	NUM
chd-200	100	11	%	%	NOUN
chd-200	100	12	)	)	PUNCT
chd-200	100	13	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	ADP
chd-200	100	14	e7	e7	PROPN
chd-200	100	15	cancer	cancer	NOUN
chd-200	100	16	health	health	NOUN
chd-200	100	17	disparities	disparity	NOUN
chd-200	100	18	research	research	VERB
chd-200	100	19	*	*	NOUN
chd-200	100	20	:	:	PUNCT
chd-200	100	21	p	p	PRON
chd-200	100	22	considered	consider	VERB
chd-200	100	23	significant	significant	ADJ
chd-200	100	24	if	if	SCONJ
chd-200	100	25	<	<	X
chd-200	100	26	0.05	0.05	NUM
chd-200	100	27	discussion	discussion	NOUN
chd-200	100	28	this	this	DET
chd-200	100	29	study	study	NOUN
chd-200	100	30	reflects	reflect	VERB
chd-200	100	31	the	the	DET
chd-200	100	32	disproportionate	disproportionate	ADJ
chd-200	100	33	effect	effect	NOUN
chd-200	100	34	of	of	ADP
chd-200	100	35	covid19	covid19	NOUN
chd-200	100	36	on	on	ADP
chd-200	100	37	aa	aa	NOUN
chd-200	100	38	with	with	ADP
chd-200	100	39	and	and	CCONJ
chd-200	100	40	without	without	ADP
chd-200	100	41	cancer	cancer	NOUN
chd-200	100	42	.	.	PUNCT
chd-200	101	1	aa	aa	PROPN
chd-200	101	2	normally	normally	ADV
chd-200	101	3	make	make	VERB
chd-200	101	4	up	up	ADP
chd-200	101	5	8.6	8.6	NUM
chd-200	101	6	%	%	NOUN
chd-200	101	7	of	of	ADP
chd-200	101	8	the	the	DET
chd-200	101	9	oncology	oncology	NOUN
chd-200	101	10	patients	patient	NOUN
chd-200	101	11	at	at	ADP
chd-200	101	12	uhscc	uhscc	ADJ
chd-200	101	13	as	as	SCONJ
chd-200	101	14	shown	show	VERB
chd-200	101	15	in	in	ADP
chd-200	101	16	the	the	DET
chd-200	101	17	ca+/covidgroup	ca+/covidgroup	NOUN
chd-200	101	18	.	.	PUNCT
chd-200	102	1	however	however	ADV
chd-200	102	2	,	,	PUNCT
chd-200	102	3	this	this	PRON
chd-200	102	4	increases	increase	VERB
chd-200	102	5	over	over	ADP
chd-200	102	6	4.5	4.5	NUM
chd-200	102	7	times	time	NOUN
chd-200	102	8	to	to	ADP
chd-200	102	9	41.0	41.0	NUM
chd-200	102	10	%	%	NOUN
chd-200	102	11	of	of	ADP
chd-200	102	12	oncology	oncology	NOUN
chd-200	102	13	patients	patient	NOUN
chd-200	102	14	with	with	ADP
chd-200	102	15	covid19	covid19	NOUN
chd-200	102	16	infections	infection	NOUN
chd-200	102	17	.	.	PUNCT
chd-200	103	1	further	further	ADJ
chd-200	103	2	studies	study	NOUN
chd-200	103	3	evaluating	evaluate	VERB
chd-200	103	4	socioeconomic	socioeconomic	ADJ
chd-200	103	5	factors	factor	NOUN
chd-200	103	6	that	that	PRON
chd-200	103	7	limit	limit	VERB
chd-200	103	8	the	the	DET
chd-200	103	9	ability	ability	NOUN
chd-200	103	10	to	to	PART
chd-200	103	11	social	social	ADJ
chd-200	103	12	distance	distance	NOUN
chd-200	103	13	or	or	CCONJ
chd-200	103	14	work	work	VERB
chd-200	103	15	remotely	remotely	ADV
chd-200	103	16	as	as	ADV
chd-200	103	17	well	well	ADV
chd-200	103	18	as	as	ADP
chd-200	103	19	other	other	ADJ
chd-200	103	20	social	social	ADJ
chd-200	103	21	determinants	determinant	NOUN
chd-200	103	22	of	of	ADP
chd-200	103	23	health	health	NOUN
chd-200	103	24	are	be	AUX
chd-200	103	25	needed	need	VERB
chd-200	103	26	to	to	PART
chd-200	103	27	determine	determine	VERB
chd-200	103	28	why	why	SCONJ
chd-200	103	29	this	this	DET
chd-200	103	30	disparity	disparity	NOUN
chd-200	103	31	exists	exist	VERB
chd-200	103	32	.	.	PUNCT
chd-200	104	1	interestingly	interestingly	ADV
chd-200	104	2	,	,	PUNCT
chd-200	104	3	the	the	DET
chd-200	104	4	proportion	proportion	NOUN
chd-200	104	5	of	of	ADP
chd-200	104	6	aa	aa	NOUN
chd-200	104	7	is	be	AUX
chd-200	104	8	even	even	ADV
chd-200	104	9	greater	great	ADJ
chd-200	104	10	(	(	PUNCT
chd-200	104	11	47.6	47.6	NUM
chd-200	104	12	%	%	NOUN
chd-200	104	13	)	)	PUNCT
chd-200	104	14	in	in	ADP
chd-200	104	15	non	non	ADJ
chd-200	104	16	-	-	ADJ
chd-200	104	17	oncologic	oncologic	ADJ
chd-200	104	18	patients	patient	NOUN
chd-200	104	19	(	(	PUNCT
chd-200	104	20	ca-/covid19	ca-/covid19	PROPN
chd-200	104	21	+	+	PROPN
chd-200	104	22	)	)	PUNCT
chd-200	104	23	than	than	ADP
chd-200	104	24	oncology	oncology	NOUN
chd-200	104	25	patients	patient	NOUN
chd-200	104	26	(	(	PUNCT
chd-200	104	27	ca+/covid19	ca+/covid19	NOUN
chd-200	104	28	+	+	NOUN
chd-200	104	29	)	)	PUNCT
chd-200	104	30	.	.	PUNCT
chd-200	105	1	to	to	ADP
chd-200	105	2	our	our	PRON
chd-200	105	3	knowledge	knowledge	NOUN
chd-200	105	4	,	,	PUNCT
chd-200	105	5	this	this	PRON
chd-200	105	6	has	have	AUX
chd-200	105	7	not	not	PART
chd-200	105	8	been	be	AUX
chd-200	105	9	previously	previously	ADV
chd-200	105	10	reported	report	VERB
chd-200	105	11	.	.	PUNCT
chd-200	106	1	cancer	cancer	NOUN
chd-200	106	2	patients	patient	NOUN
chd-200	106	3	may	may	AUX
chd-200	106	4	be	be	AUX
chd-200	106	5	taking	take	VERB
chd-200	106	6	additional	additional	ADJ
chd-200	106	7	precautions	precaution	NOUN
chd-200	106	8	that	that	PRON
chd-200	106	9	ameliorate	ameliorate	VERB
chd-200	106	10	identified	identify	VERB
chd-200	106	11	factors	factor	NOUN
chd-200	106	12	predisposing	predispose	VERB
chd-200	106	13	this	this	DET
chd-200	106	14	community	community	NOUN
chd-200	106	15	to	to	PART
chd-200	106	16	covid198,12	covid198,12	VERB
chd-200	106	17	.	.	PUNCT
chd-200	107	1	alternatively	alternatively	ADV
chd-200	107	2	,	,	PUNCT
chd-200	107	3	the	the	DET
chd-200	107	4	smaller	small	ADJ
chd-200	107	5	proportion	proportion	NOUN
chd-200	107	6	of	of	ADP
chd-200	107	7	aa	aa	NOUN
chd-200	107	8	among	among	ADP
chd-200	107	9	cancer	cancer	NOUN
chd-200	107	10	patients	patient	NOUN
chd-200	107	11	could	could	AUX
chd-200	107	12	reflect	reflect	VERB
chd-200	107	13	impaired	impaired	ADJ
chd-200	107	14	access	access	NOUN
chd-200	107	15	to	to	ADP
chd-200	107	16	cancer	cancer	NOUN
chd-200	107	17	care	care	NOUN
chd-200	107	18	which	which	PRON
chd-200	107	19	would	would	AUX
chd-200	107	20	decrease	decrease	VERB
chd-200	107	21	the	the	DET
chd-200	107	22	likelihood	likelihood	NOUN
chd-200	107	23	of	of	ADP
chd-200	107	24	covid19	covid19	NOUN
chd-200	107	25	testing	testing	NOUN
chd-200	107	26	;	;	PUNCT
chd-200	107	27	such	such	DET
chd-200	107	28	an	an	DET
chd-200	107	29	investigation	investigation	NOUN
chd-200	107	30	was	be	AUX
chd-200	107	31	beyond	beyond	ADP
chd-200	107	32	the	the	DET
chd-200	107	33	scope	scope	NOUN
chd-200	107	34	of	of	ADP
chd-200	107	35	this	this	DET
chd-200	107	36	report	report	NOUN
chd-200	107	37	.	.	PUNCT
chd-200	108	1	there	there	PRON
chd-200	108	2	was	be	VERB
chd-200	108	3	no	no	DET
chd-200	108	4	difference	difference	NOUN
chd-200	108	5	in	in	ADP
chd-200	108	6	ventilator	ventilator	NOUN
chd-200	108	7	use	use	NOUN
chd-200	108	8	,	,	PUNCT
chd-200	108	9	icu	icu	PROPN
chd-200	108	10	admission	admission	NOUN
chd-200	108	11	,	,	PUNCT
chd-200	108	12	or	or	CCONJ
chd-200	108	13	death	death	NOUN
chd-200	108	14	in	in	ADP
chd-200	108	15	cancer	cancer	NOUN
chd-200	108	16	patients	patient	NOUN
chd-200	108	17	with	with	ADP
chd-200	108	18	covid19	covid19	NOUN
chd-200	108	19	versus	versus	ADP
chd-200	108	20	patients	patient	NOUN
chd-200	108	21	without	without	ADP
chd-200	108	22	cancer	cancer	NOUN
chd-200	108	23	.	.	PUNCT
chd-200	109	1	this	this	DET
chd-200	109	2	finding	finding	NOUN
chd-200	109	3	remained	remain	VERB
chd-200	109	4	true	true	ADJ
chd-200	109	5	when	when	SCONJ
chd-200	109	6	stratified	stratify	VERB
chd-200	109	7	by	by	ADP
chd-200	109	8	race	race	NOUN
chd-200	109	9	.	.	PUNCT
chd-200	110	1	this	this	DET
chd-200	110	2	absence	absence	NOUN
chd-200	110	3	of	of	ADP
chd-200	110	4	difference	difference	NOUN
chd-200	110	5	in	in	ADP
chd-200	110	6	covid19	covid19	NOUN
chd-200	110	7	related	relate	VERB
chd-200	110	8	complications	complication	NOUN
chd-200	110	9	occurred	occur	VERB
chd-200	110	10	despite	despite	SCONJ
chd-200	110	11	cancer	cancer	NOUN
chd-200	110	12	patients	patient	NOUN
chd-200	110	13	having	have	VERB
chd-200	110	14	a	a	DET
chd-200	110	15	greater	great	ADJ
chd-200	110	16	proportion	proportion	NOUN
chd-200	110	17	of	of	ADP
chd-200	110	18	patients	patient	NOUN
chd-200	110	19	with	with	ADP
chd-200	110	20	elevated	elevated	ADJ
chd-200	110	21	comorbidity	comorbidity	NOUN
chd-200	110	22	scores	score	NOUN
chd-200	110	23	and	and	CCONJ
chd-200	110	24	could	could	AUX
chd-200	110	25	be	be	AUX
chd-200	110	26	related	relate	VERB
chd-200	110	27	to	to	ADP
chd-200	110	28	the	the	DET
chd-200	110	29	low	low	ADJ
chd-200	110	30	percentage	percentage	NOUN
chd-200	110	31	of	of	ADP
chd-200	110	32	patients	patient	NOUN
chd-200	110	33	receiving	receive	VERB
chd-200	110	34	active	active	ADJ
chd-200	110	35	treatment	treatment	NOUN
chd-200	110	36	,	,	PUNCT
chd-200	110	37	a	a	DET
chd-200	110	38	known	know	VERB
chd-200	110	39	risk	risk	NOUN
chd-200	110	40	factor	factor	NOUN
chd-200	110	41	for	for	ADP
chd-200	110	42	worse	bad	ADJ
chd-200	110	43	outcomes	outcome	NOUN
chd-200	110	44	4,7,13–15	4,7,13–15	NUM
chd-200	110	45	.	.	PUNCT
chd-200	111	1	this	this	DET
chd-200	111	2	study	study	NOUN
chd-200	111	3	has	have	VERB
chd-200	111	4	several	several	ADJ
chd-200	111	5	limitations	limitation	NOUN
chd-200	111	6	.	.	PUNCT
chd-200	112	1	given	give	VERB
chd-200	112	2	its	its	PRON
chd-200	112	3	retrospective	retrospective	ADJ
chd-200	112	4	nature	nature	NOUN
chd-200	112	5	,	,	PUNCT
chd-200	112	6	it	it	PRON
chd-200	112	7	was	be	AUX
chd-200	112	8	not	not	PART
chd-200	112	9	possible	possible	ADJ
chd-200	112	10	to	to	PART
chd-200	112	11	control	control	VERB
chd-200	112	12	for	for	ADP
chd-200	112	13	rapidly	rapidly	ADV
chd-200	112	14	evolving	evolve	VERB
chd-200	112	15	covid19	covid19	NOUN
chd-200	112	16	care	care	NOUN
chd-200	112	17	,	,	PUNCT
chd-200	112	18	however	however	ADV
chd-200	112	19	,	,	PUNCT
chd-200	112	20	the	the	DET
chd-200	112	21	limited	limited	ADJ
chd-200	112	22	time	time	NOUN
chd-200	112	23	frame	frame	NOUN
chd-200	112	24	of	of	ADP
chd-200	112	25	interest	interest	NOUN
chd-200	112	26	minimizes	minimize	VERB
chd-200	112	27	the	the	DET
chd-200	112	28	effects	effect	NOUN
chd-200	112	29	of	of	ADP
chd-200	112	30	cancer	cancer	NOUN
chd-200	112	31	care	care	NOUN
chd-200	112	32	specifics	specific	NOUN
chd-200	112	33	to	to	ADP
chd-200	112	34	mortality	mortality	NOUN
chd-200	112	35	and	and	CCONJ
chd-200	112	36	morbidity	morbidity	NOUN
chd-200	112	37	.	.	PUNCT
chd-200	113	1	the	the	DET
chd-200	113	2	study	study	NOUN
chd-200	113	3	population	population	NOUN
chd-200	113	4	was	be	AUX
chd-200	113	5	that	that	PRON
chd-200	113	6	of	of	ADP
chd-200	113	7	a	a	DET
chd-200	113	8	large	large	ADJ
chd-200	113	9	urban	urban	ADJ
chd-200	113	10	academic	academic	ADJ
chd-200	113	11	center	center	NOUN
chd-200	113	12	and	and	CCONJ
chd-200	113	13	may	may	AUX
chd-200	113	14	not	not	PART
chd-200	113	15	represent	represent	VERB
chd-200	113	16	other	other	ADJ
chd-200	113	17	patient	patient	ADJ
chd-200	113	18	groups	group	NOUN
chd-200	113	19	.	.	PUNCT
chd-200	114	1	this	this	DET
chd-200	114	2	study	study	NOUN
chd-200	114	3	illustrates	illustrate	VERB
chd-200	114	4	the	the	DET
chd-200	114	5	disproportionate	disproportionate	ADJ
chd-200	114	6	effect	effect	NOUN
chd-200	114	7	of	of	ADP
chd-200	114	8	covid19	covid19	NOUN
chd-200	114	9	on	on	ADP
chd-200	114	10	aa	aa	NOUN
chd-200	114	11	oncology	oncology	NOUN
chd-200	114	12	patients	patient	NOUN
chd-200	114	13	.	.	PUNCT
chd-200	115	1	despite	despite	SCONJ
chd-200	115	2	similar	similar	ADJ
chd-200	115	3	rates	rate	NOUN
chd-200	115	4	of	of	ADP
chd-200	115	5	adverse	adverse	ADJ
chd-200	115	6	outcomes	outcome	NOUN
chd-200	115	7	to	to	PART
chd-200	115	8	covid19	covid19	VERB
chd-200	115	9	amongst	amongst	ADP
chd-200	115	10	racial	racial	ADJ
chd-200	115	11	groups	group	NOUN
chd-200	115	12	,	,	PUNCT
chd-200	115	13	the	the	DET
chd-200	115	14	proportion	proportion	NOUN
chd-200	115	15	of	of	ADP
chd-200	115	16	aa	aa	NOUN
chd-200	115	17	patients	patient	NOUN
chd-200	115	18	was	be	AUX
chd-200	115	19	significantly	significantly	ADV
chd-200	115	20	higher	high	ADJ
chd-200	115	21	among	among	ADP
chd-200	115	22	cancer	cancer	NOUN
chd-200	115	23	patients	patient	NOUN
chd-200	115	24	with	with	ADP
chd-200	115	25	covid19	covid19	NOUN
chd-200	115	26	when	when	SCONJ
chd-200	115	27	compared	compare	VERB
chd-200	115	28	with	with	ADP
chd-200	115	29	controls	control	NOUN
chd-200	115	30	without	without	ADP
chd-200	115	31	covid19	covid19	NOUN
chd-200	115	32	.	.	PUNCT
chd-200	116	1	these	these	DET
chd-200	116	2	findings	finding	NOUN
chd-200	116	3	suggest	suggest	VERB
chd-200	116	4	racial	racial	ADJ
chd-200	116	5	differences	difference	NOUN
chd-200	116	6	in	in	ADP
chd-200	116	7	covid19	covid19	NOUN
chd-200	116	8	rates	rate	NOUN
chd-200	116	9	in	in	ADP
chd-200	116	10	the	the	DET
chd-200	116	11	oncology	oncology	NOUN
chd-200	116	12	population	population	NOUN
chd-200	116	13	should	should	AUX
chd-200	116	14	inform	inform	VERB
chd-200	116	15	infection	infection	NOUN
chd-200	116	16	control	control	NOUN
chd-200	116	17	efforts	effort	NOUN
chd-200	116	18	like	like	ADP
chd-200	116	19	vaccination	vaccination	NOUN
chd-200	116	20	programs	program	NOUN
chd-200	116	21	as	as	ADV
chd-200	116	22	well	well	ADV
chd-200	116	23	as	as	ADP
chd-200	116	24	future	future	ADJ
chd-200	116	25	study	study	NOUN
chd-200	116	26	designs	design	NOUN
chd-200	116	27	to	to	PART
chd-200	116	28	protect	protect	VERB
chd-200	116	29	vulnerable	vulnerable	ADJ
chd-200	116	30	populations	population	NOUN
chd-200	116	31	.	.	PUNCT
chd-200	117	1	acknowledgement	acknowledgement	NOUN
chd-200	117	2	none	none	NOUN
chd-200	117	3	conflicts	conflict	NOUN
chd-200	117	4	of	of	ADP
chd-200	117	5	interest	interest	NOUN
chd-200	117	6	the	the	DET
chd-200	117	7	authors	author	NOUN
chd-200	117	8	declare	declare	VERB
chd-200	117	9	no	no	DET
chd-200	117	10	conflict	conflict	NOUN
chd-200	117	11	of	of	ADP
chd-200	117	12	interest	interest	NOUN
chd-200	117	13	.	.	PUNCT
chd-200	118	1	authors	author	NOUN
chd-200	118	2	'	'	PART
chd-200	118	3	contributions	contribution	NOUN
chd-200	118	4	design	design	NOUN
chd-200	118	5	:	:	PUNCT
chd-200	118	6	nakayama	nakayama	PROPN
chd-200	118	7	,	,	PUNCT
chd-200	118	8	cioffi	cioffi	PROPN
chd-200	118	9	,	,	PUNCT
chd-200	118	10	waite	waite	PROPN
chd-200	118	11	,	,	PUNCT
chd-200	118	12	sellers	seller	NOUN
chd-200	118	13	,	,	PUNCT
chd-200	118	14	barnholtzsloan	barnholtzsloan	NOUN
chd-200	118	15	,	,	PUNCT
chd-200	118	16	caimi	caimi	ADJ
chd-200	118	17	,	,	PUNCT
chd-200	118	18	sellers	seller	NOUN
chd-200	118	19	data	data	VERB
chd-200	118	20	collection	collection	NOUN
chd-200	118	21	:	:	PUNCT
chd-200	118	22	nakayama	nakayama	PROPN
chd-200	118	23	,	,	PUNCT
chd-200	118	24	iyer	iyer	PROPN
chd-200	118	25	,	,	PUNCT
chd-200	118	26	kyasaram	kyasaram	PROPN
chd-200	118	27	,	,	PUNCT
chd-200	118	28	shanahan	shanahan	PROPN
chd-200	118	29	analysis	analysis	NOUN
chd-200	118	30	:	:	PUNCT
chd-200	118	31	nakayama	nakayama	PROPN
chd-200	118	32	,	,	PUNCT
chd-200	118	33	cioffi	cioffi	PROPN
chd-200	118	34	,	,	PUNCT
chd-200	118	35	iyer	iyer	PROPN
chd-200	118	36	,	,	PUNCT
chd-200	118	37	caimi	caimi	PROPN
chd-200	118	38	,	,	PUNCT
chd-200	118	39	waite	waite	PROPN
chd-200	118	40	,	,	PUNCT
chd-200	118	41	sellers	seller	NOUN
chd-200	118	42	,	,	PUNCT
chd-200	118	43	barnholtz	barnholtz	NOUN
chd-200	118	44	-	-	PUNCT
chd-200	118	45	sloan	sloan	NOUN
chd-200	118	46	manuscript	manuscript	NOUN
chd-200	118	47	:	:	PUNCT
chd-200	118	48	nakayama	nakayama	PROPN
chd-200	118	49	,	,	PUNCT
chd-200	118	50	cioffi	cioffi	PROPN
chd-200	118	51	,	,	PUNCT
chd-200	118	52	iyer	iyer	PROPN
chd-200	118	53	,	,	PUNCT
chd-200	118	54	caimi	caimi	PROPN
chd-200	118	55	,	,	PUNCT
chd-200	118	56	waite	waite	PROPN
chd-200	118	57	,	,	PUNCT
chd-200	118	58	sellers	seller	NOUN
chd-200	118	59	,	,	PUNCT
chd-200	118	60	barnholtz	barnholtz	NOUN
chd-200	118	61	-	-	PUNCT
chd-200	118	62	sloan	sloan	NOUN
chd-200	118	63	references	reference	NOUN
chd-200	118	64	1	1	NUM
chd-200	118	65	.	.	PUNCT
chd-200	119	1	liang	liang	PROPN
chd-200	119	2	w	w	PROPN
chd-200	119	3	,	,	PUNCT
chd-200	119	4	guan	guan	PROPN
chd-200	119	5	w	w	PROPN
chd-200	119	6	,	,	PUNCT
chd-200	119	7	chen	chen	PROPN
chd-200	119	8	r	r	PROPN
chd-200	119	9	,	,	PUNCT
chd-200	119	10	et	et	PROPN
chd-200	119	11	al	al	PROPN
chd-200	119	12	.	.	PUNCT
chd-200	120	1	cancer	cancer	NOUN
chd-200	120	2	patients	patient	NOUN
chd-200	120	3	in	in	ADP
chd-200	120	4	sarscov-2	sarscov-2	NUM
chd-200	120	5	infection	infection	NOUN
chd-200	120	6	:	:	PUNCT
chd-200	120	7	a	a	DET
chd-200	120	8	nationwide	nationwide	ADJ
chd-200	120	9	analysis	analysis	NOUN
chd-200	120	10	in	in	ADP
chd-200	120	11	china	china	PROPN
chd-200	120	12	.	.	PUNCT
chd-200	121	1	lancet	lancet	PROPN
chd-200	121	2	oncol	oncol	PROPN
chd-200	121	3	.	.	PUNCT
chd-200	122	1	2020;21(3):335	2020;21(3):335	NUM
chd-200	122	2	-	-	SYM
chd-200	122	3	337	337	NUM
chd-200	122	4	.	.	PUNCT
chd-200	123	1	doi:10.1016	doi:10.1016	PROPN
chd-200	123	2	/	/	SYM
chd-200	123	3	s14702045(20)30096	s14702045(20)30096	NOUN
chd-200	123	4	-	-	PUNCT
chd-200	123	5	6	6	NUM
chd-200	123	6	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-200	123	7	e8	e8	PROPN
chd-200	123	8	cancer	cancer	NOUN
chd-200	123	9	health	health	NOUN
chd-200	123	10	disparities	disparity	NOUN
chd-200	123	11	research	research	VERB
chd-200	123	12	2	2	NUM
chd-200	123	13	.	.	PUNCT
chd-200	123	14	trapani	trapani	PROPN
chd-200	124	1	d	d	X
chd-200	124	2	,	,	PUNCT
chd-200	124	3	marra	marra	PROPN
chd-200	124	4	a	a	X
chd-200	124	5	,	,	PUNCT
chd-200	124	6	curigliano	curigliano	NOUN
chd-200	124	7	g.	g.	NOUN
chd-200	125	1	the	the	DET
chd-200	125	2	experience	experience	NOUN
chd-200	125	3	on	on	ADP
chd-200	125	4	coronavirus	coronavirus	NOUN
chd-200	125	5	disease	disease	NOUN
chd-200	125	6	2019	2019	NUM
chd-200	125	7	and	and	CCONJ
chd-200	125	8	cancer	cancer	NOUN
chd-200	125	9	from	from	ADP
chd-200	125	10	an	an	DET
chd-200	125	11	oncology	oncology	NOUN
chd-200	125	12	hub	hub	NOUN
chd-200	125	13	institution	institution	NOUN
chd-200	125	14	in	in	ADP
chd-200	125	15	milan	milan	PROPN
chd-200	125	16	,	,	PUNCT
chd-200	125	17	lombardy	lombardy	PROPN
chd-200	125	18	region	region	PROPN
chd-200	125	19	.	.	PUNCT
chd-200	126	1	eur	eur	PROPN
chd-200	126	2	j	j	PROPN
chd-200	126	3	cancer	cancer	NOUN
chd-200	126	4	.	.	PUNCT
chd-200	127	1	2020;132:199	2020;132:199	NUM
chd-200	127	2	-	-	SYM
chd-200	127	3	206	206	NUM
chd-200	127	4	.	.	PUNCT
chd-200	128	1	doi:10.1016	doi:10.1016	PROPN
chd-200	128	2	/	/	SYM
chd-200	128	3	j.ejca.2020.04.017	j.ejca.2020.04.017	CCONJ
chd-200	128	4	3	3	NUM
chd-200	128	5	.	.	PUNCT
chd-200	129	1	mehta	mehta	PROPN
chd-200	129	2	v	v	PROPN
chd-200	129	3	,	,	PUNCT
chd-200	129	4	goel	goel	PROPN
chd-200	129	5	s	s	PROPN
chd-200	129	6	,	,	PUNCT
chd-200	129	7	kabarriti	kabarriti	PROPN
chd-200	129	8	r	r	NOUN
chd-200	129	9	,	,	PUNCT
chd-200	129	10	et	et	PROPN
chd-200	129	11	al	al	PROPN
chd-200	129	12	.	.	PROPN
chd-200	129	13	case	case	NOUN
chd-200	129	14	fatality	fatality	NOUN
chd-200	129	15	rate	rate	NOUN
chd-200	129	16	of	of	ADP
chd-200	129	17	cancer	cancer	NOUN
chd-200	129	18	patients	patient	NOUN
chd-200	129	19	with	with	ADP
chd-200	129	20	covid-19	covid-19	PROPN
chd-200	129	21	in	in	ADP
chd-200	129	22	a	a	DET
chd-200	129	23	new	new	PROPN
chd-200	129	24	york	york	PROPN
chd-200	129	25	hospital	hospital	NOUN
chd-200	129	26	system	system	NOUN
chd-200	129	27	.	.	PUNCT
chd-200	130	1	cancer	cancer	NOUN
chd-200	130	2	discov	discov	NOUN
chd-200	130	3	.	.	PUNCT
chd-200	131	1	2020;10(7):935	2020;10(7):935	PROPN
chd-200	131	2	-	-	SYM
chd-200	131	3	941	941	NUM
chd-200	131	4	.	.	PUNCT
chd-200	132	1	doi:10.1158/2159	doi:10.1158/2159	NOUN
chd-200	132	2	-	-	PUNCT
chd-200	132	3	8290.cd-20	8290.cd-20	NUM
chd-200	132	4	-	-	PUNCT
chd-200	132	5	0516	0516	NUM
chd-200	132	6	4	4	NUM
chd-200	132	7	.	.	PUNCT
chd-200	132	8	rugge	rugge	PROPN
chd-200	132	9	m	m	PROPN
chd-200	132	10	,	,	PUNCT
chd-200	132	11	zorzi	zorzi	PROPN
chd-200	132	12	m	m	PROPN
chd-200	132	13	,	,	PUNCT
chd-200	132	14	guzzinati	guzzinati	PROPN
chd-200	132	15	s.	s.	PROPN
chd-200	132	16	sars	sars	PROPN
chd-200	132	17	-	-	PUNCT
chd-200	132	18	cov-2	cov-2	PART
chd-200	132	19	infection	infection	NOUN
chd-200	132	20	in	in	ADP
chd-200	132	21	the	the	DET
chd-200	132	22	italian	italian	ADJ
chd-200	132	23	veneto	veneto	NOUN
chd-200	132	24	region	region	NOUN
chd-200	132	25	:	:	PUNCT
chd-200	132	26	adverse	adverse	ADJ
chd-200	132	27	outcomes	outcome	NOUN
chd-200	132	28	in	in	ADP
chd-200	132	29	patients	patient	NOUN
chd-200	132	30	with	with	ADP
chd-200	132	31	cancer	cancer	NOUN
chd-200	132	32	.	.	PUNCT
chd-200	133	1	nat	nat	NOUN
chd-200	133	2	cancer	cancer	NOUN
chd-200	133	3	.	.	PUNCT
chd-200	134	1	2020;1(8):784	2020;1(8):784	X
chd-200	134	2	-	-	PUNCT
chd-200	134	3	788	788	NUM
chd-200	134	4	.	.	PUNCT
chd-200	135	1	doi:10.1038	doi:10.1038	NOUN
chd-200	135	2	/	/	SYM
chd-200	135	3	s43018	s43018	NOUN
chd-200	135	4	-	-	PUNCT
chd-200	135	5	020	020	NUM
chd-200	135	6	-	-	PUNCT
chd-200	135	7	0104	0104	NUM
chd-200	135	8	-	-	SYM
chd-200	135	9	9	9	NUM
chd-200	135	10	5	5	NUM
chd-200	135	11	.	.	PUNCT
chd-200	136	1	robilotti	robilotti	PROPN
chd-200	136	2	e	e	PROPN
chd-200	136	3	v.	v.	PROPN
chd-200	136	4	,	,	PUNCT
chd-200	136	5	babady	babady	PROPN
chd-200	136	6	ne	ne	NOUN
chd-200	136	7	,	,	PUNCT
chd-200	136	8	mead	mead	PROPN
chd-200	136	9	pa	pa	PROPN
chd-200	136	10	,	,	PUNCT
chd-200	136	11	et	et	PROPN
chd-200	136	12	al	al	PROPN
chd-200	136	13	.	.	PUNCT
chd-200	137	1	determinants	determinant	NOUN
chd-200	137	2	of	of	ADP
chd-200	137	3	covid-19	covid-19	PROPN
chd-200	137	4	disease	disease	NOUN
chd-200	137	5	severity	severity	NOUN
chd-200	137	6	in	in	ADP
chd-200	137	7	patients	patient	NOUN
chd-200	137	8	with	with	ADP
chd-200	137	9	cancer	cancer	NOUN
chd-200	137	10	.	.	PUNCT
chd-200	138	1	nat	nat	PROPN
chd-200	138	2	med	med	PROPN
chd-200	138	3	.	.	PUNCT
chd-200	139	1	2020;26(8):1218	2020;26(8):1218	NOUN
chd-200	139	2	-	-	PUNCT
chd-200	139	3	1223	1223	NUM
chd-200	139	4	.	.	PUNCT
chd-200	140	1	doi:10.1038	doi:10.1038	NOUN
chd-200	140	2	/	/	SYM
chd-200	140	3	s41591	s41591	NOUN
chd-200	140	4	-	-	PUNCT
chd-200	140	5	020	020	NUM
chd-200	140	6	-	-	PUNCT
chd-200	140	7	09790	09790	NUM
chd-200	140	8	6	6	NUM
chd-200	140	9	.	.	PUNCT
chd-200	141	1	kabarriti	kabarriti	PROPN
chd-200	141	2	r	r	NOUN
chd-200	141	3	,	,	PUNCT
chd-200	141	4	brodin	brodin	NOUN
chd-200	141	5	np	np	PROPN
chd-200	141	6	,	,	PUNCT
chd-200	141	7	maron	maron	PROPN
chd-200	141	8	mi	mi	PROPN
chd-200	141	9	,	,	PUNCT
chd-200	141	10	et	et	PROPN
chd-200	141	11	al	al	PROPN
chd-200	141	12	.	.	PROPN
chd-200	141	13	association	association	PROPN
chd-200	141	14	of	of	ADP
chd-200	141	15	race	race	NOUN
chd-200	141	16	and	and	CCONJ
chd-200	141	17	ethnicity	ethnicity	NOUN
chd-200	141	18	with	with	ADP
chd-200	141	19	comorbidities	comorbiditie	NOUN
chd-200	141	20	and	and	CCONJ
chd-200	141	21	survival	survival	NOUN
chd-200	141	22	among	among	ADP
chd-200	141	23	patients	patient	NOUN
chd-200	141	24	with	with	ADP
chd-200	141	25	covid-19	covid-19	PROPN
chd-200	141	26	at	at	ADP
chd-200	141	27	an	an	DET
chd-200	141	28	urban	urban	ADJ
chd-200	141	29	medical	medical	ADJ
chd-200	141	30	center	center	NOUN
chd-200	141	31	in	in	ADP
chd-200	141	32	new	new	PROPN
chd-200	141	33	york	york	PROPN
chd-200	141	34	.	.	PUNCT
chd-200	142	1	jama	jama	PROPN
chd-200	142	2	netw	netw	PROPN
chd-200	142	3	open	open	ADJ
chd-200	142	4	.	.	PUNCT
chd-200	143	1	2020;3(9):e2019795	2020;3(9):e2019795	X
chd-200	143	2	.	.	PUNCT
chd-200	144	1	doi:10.1001	doi:10.1001	PROPN
chd-200	144	2	/	/	SYM
chd-200	144	3	jamanetworkopen.2020.19795	jamanetworkopen.2020.19795	PROPN
chd-200	144	4	7	7	NUM
chd-200	144	5	.	.	PUNCT
chd-200	145	1	dai	dai	PROPN
chd-200	145	2	m	m	PROPN
chd-200	145	3	,	,	PUNCT
chd-200	145	4	liu	liu	PROPN
chd-200	145	5	d	d	PROPN
chd-200	145	6	,	,	PUNCT
chd-200	145	7	liu	liu	PROPN
chd-200	145	8	m	m	PROPN
chd-200	145	9	,	,	PUNCT
chd-200	145	10	et	et	PROPN
chd-200	145	11	al	al	PROPN
chd-200	145	12	.	.	PUNCT
chd-200	146	1	patients	patient	NOUN
chd-200	146	2	with	with	ADP
chd-200	146	3	cancer	cancer	NOUN
chd-200	146	4	appear	appear	VERB
chd-200	146	5	more	more	ADV
chd-200	146	6	vulnerable	vulnerable	ADJ
chd-200	146	7	to	to	ADP
chd-200	146	8	sars	sar	NOUN
chd-200	146	9	-	-	PUNCT
chd-200	146	10	cov-2	cov-2	NOUN
chd-200	146	11	:	:	PUNCT
chd-200	146	12	a	a	DET
chd-200	146	13	multicenter	multicenter	ADJ
chd-200	146	14	study	study	NOUN
chd-200	146	15	during	during	ADP
chd-200	146	16	the	the	DET
chd-200	146	17	covid-19	covid-19	PROPN
chd-200	146	18	outbreak	outbreak	NOUN
chd-200	146	19	.	.	PUNCT
chd-200	147	1	cancer	cancer	NOUN
chd-200	147	2	discov	discov	NOUN
chd-200	147	3	.	.	PUNCT
chd-200	148	1	2020;10(6):783	2020;10(6):783	NOUN
chd-200	148	2	.	.	PUNCT
chd-200	149	1	doi:10.1158/2159	doi:10.1158/2159	NOUN
chd-200	149	2	-	-	PUNCT
chd-200	149	3	8290.cd-20	8290.cd-20	NUM
chd-200	149	4	-	-	PUNCT
chd-200	149	5	0422	0422	NUM
chd-200	149	6	8	8	NUM
chd-200	149	7	.	.	PUNCT
chd-200	149	8	balogun	balogun	VERB
chd-200	149	9	od	od	PROPN
chd-200	149	10	,	,	PUNCT
chd-200	149	11	bea	bea	PROPN
chd-200	149	12	vj	vj	PROPN
chd-200	149	13	,	,	PUNCT
chd-200	149	14	phillips	phillips	PROPN
chd-200	149	15	e.	e.	PROPN
chd-200	149	16	disparities	disparity	NOUN
chd-200	149	17	in	in	ADP
chd-200	149	18	cancer	cancer	NOUN
chd-200	149	19	outcomes	outcome	NOUN
chd-200	149	20	due	due	ADP
chd-200	149	21	to	to	ADP
chd-200	149	22	covid-19	covid-19	PROPN
chd-200	149	23	a	a	DET
chd-200	149	24	tale	tale	NOUN
chd-200	149	25	of	of	ADP
chd-200	149	26	2	2	NUM
chd-200	149	27	cities	city	NOUN
chd-200	149	28	.	.	PUNCT
chd-200	150	1	jama	jama	PROPN
chd-200	150	2	oncol	oncol	ADJ
chd-200	150	3	.	.	PUNCT
chd-200	151	1	2020;6(10):1531	2020;6(10):1531	NUM
chd-200	151	2	-	-	SYM
chd-200	151	3	1532	1532	NUM
chd-200	151	4	.	.	PUNCT
chd-200	152	1	doi:10.1001	doi:10.1001	PROPN
chd-200	152	2	/	/	SYM
chd-200	152	3	jamaoncol.2020.3327	jamaoncol.2020.3327	NOUN
chd-200	152	4	9	9	NUM
chd-200	152	5	.	.	PUNCT
chd-200	153	1	fillmore	fillmore	PROPN
chd-200	153	2	nr	nr	PROPN
chd-200	153	3	,	,	PUNCT
chd-200	153	4	la	la	PROPN
chd-200	153	5	j	j	PROPN
chd-200	153	6	,	,	PUNCT
chd-200	153	7	szalat	szalat	NOUN
chd-200	153	8	re	re	PROPN
chd-200	153	9	,	,	PUNCT
chd-200	153	10	et	et	PROPN
chd-200	153	11	al	al	PROPN
chd-200	153	12	.	.	PUNCT
chd-200	153	13	prevalence	prevalence	NOUN
chd-200	153	14	and	and	CCONJ
chd-200	153	15	outcome	outcome	NOUN
chd-200	153	16	of	of	ADP
chd-200	153	17	covid-19	covid-19	PROPN
chd-200	153	18	infection	infection	NOUN
chd-200	153	19	in	in	ADP
chd-200	153	20	cancer	cancer	NOUN
chd-200	153	21	patients	patient	NOUN
chd-200	153	22	:	:	PUNCT
chd-200	153	23	a	a	DET
chd-200	153	24	national	national	ADJ
chd-200	153	25	veterans	veterans	PROPN
chd-200	153	26	affairs	affair	NOUN
chd-200	153	27	study	study	PROPN
chd-200	153	28	.	.	PUNCT
chd-200	154	1	j	j	PROPN
chd-200	154	2	natl	natl	PROPN
chd-200	154	3	cancer	cancer	PROPN
chd-200	154	4	inst	inst	PROPN
chd-200	154	5	.	.	PUNCT
chd-200	155	1	2020	2020	NUM
chd-200	155	2	.	.	PUNCT
chd-200	156	1	doi:10.1093	doi:10.1093	NOUN
chd-200	156	2	/	/	SYM
chd-200	156	3	jnci	jnci	PROPN
chd-200	156	4	/	/	SYM
chd-200	156	5	djaa159	djaa159	PROPN
chd-200	156	6	10	10	NUM
chd-200	156	7	.	.	PUNCT
chd-200	157	1	thompson	thompson	PROPN
chd-200	157	2	nr	nr	PROPN
chd-200	157	3	,	,	PUNCT
chd-200	157	4	fan	fan	PROPN
chd-200	157	5	y	y	PROPN
chd-200	157	6	,	,	PUNCT
chd-200	157	7	dalton	dalton	PROPN
chd-200	157	8	je	je	PROPN
chd-200	157	9	,	,	PUNCT
chd-200	157	10	et	et	PROPN
chd-200	157	11	al	al	PROPN
chd-200	157	12	.	.	PUNCT
chd-200	158	1	a	a	DET
chd-200	158	2	new	new	ADJ
chd-200	158	3	elixhauserbased	elixhauserbased	ADJ
chd-200	158	4	comorbidity	comorbidity	NOUN
chd-200	158	5	summary	summary	NOUN
chd-200	158	6	measure	measure	NOUN
chd-200	158	7	to	to	PART
chd-200	158	8	predict	predict	VERB
chd-200	158	9	inhospital	inhospital	ADJ
chd-200	158	10	mortality	mortality	NOUN
chd-200	158	11	.	.	PUNCT
chd-200	159	1	med	med	ADJ
chd-200	159	2	care	care	NOUN
chd-200	159	3	.	.	PUNCT
chd-200	160	1	2015;53(4):374	2015;53(4):374	NUM
chd-200	160	2	-	-	SYM
chd-200	160	3	379	379	NUM
chd-200	160	4	.	.	PUNCT
chd-200	161	1	doi:10.1097	doi:10.1097	PROPN
chd-200	161	2	/	/	SYM
chd-200	161	3	mlr.0000000000000326	mlr.0000000000000326	PRON
chd-200	161	4	11	11	NUM
chd-200	161	5	.	.	PUNCT
chd-200	162	1	moore	moore	PROPN
chd-200	162	2	bj	bj	PROPN
chd-200	162	3	,	,	PUNCT
chd-200	162	4	white	white	PROPN
chd-200	162	5	s	s	PROPN
chd-200	162	6	,	,	PUNCT
chd-200	162	7	washington	washington	PROPN
chd-200	162	8	r	r	PROPN
chd-200	162	9	,	,	PUNCT
chd-200	162	10	coenen	coenen	NOUN
chd-200	162	11	n	n	CCONJ
chd-200	162	12	,	,	PUNCT
chd-200	162	13	elixhauser	elixhauser	ADJ
chd-200	162	14	a.	a.	NOUN
chd-200	162	15	identifying	identify	VERB
chd-200	162	16	increased	increase	VERB
chd-200	162	17	risk	risk	NOUN
chd-200	162	18	of	of	ADP
chd-200	162	19	readmission	readmission	NOUN
chd-200	162	20	and	and	CCONJ
chd-200	162	21	inhospital	inhospital	ADJ
chd-200	162	22	mortality	mortality	NOUN
chd-200	162	23	using	use	VERB
chd-200	162	24	hospital	hospital	NOUN
chd-200	162	25	administrative	administrative	ADJ
chd-200	162	26	data	data	PROPN
chd-200	162	27	.	.	PUNCT
chd-200	163	1	med	med	ADJ
chd-200	163	2	care	care	NOUN
chd-200	163	3	.	.	PUNCT
chd-200	164	1	2017;55(7):698	2017;55(7):698	NUM
chd-200	164	2	-	-	PUNCT
chd-200	164	3	705	705	NUM
chd-200	164	4	.	.	PUNCT
chd-200	165	1	doi:10.1097/	doi:10.1097/	NUM
chd-200	165	2	mlr.0000000000000735	mlr.0000000000000735	NOUN
chd-200	165	3	12	12	NUM
chd-200	165	4	.	.	PUNCT
chd-200	166	1	newman	newman	PROPN
chd-200	166	2	l	l	PROPN
chd-200	166	3	,	,	PUNCT
chd-200	166	4	winn	winn	PROPN
chd-200	166	5	ra	ra	PROPN
chd-200	166	6	,	,	PUNCT
chd-200	166	7	carethers	carethers	PROPN
chd-200	166	8	jm	jm	PROPN
chd-200	166	9	.	.	PROPN
chd-200	166	10	similarities	similarity	NOUN
chd-200	166	11	in	in	ADP
chd-200	166	12	risk	risk	NOUN
chd-200	166	13	for	for	ADP
chd-200	166	14	covid-19	covid-19	PROPN
chd-200	166	15	and	and	CCONJ
chd-200	166	16	cancer	cancer	NOUN
chd-200	166	17	disparities	disparity	NOUN
chd-200	166	18	.	.	PUNCT
chd-200	167	1	clin	clin	PROPN
chd-200	167	2	cancer	cancer	NOUN
chd-200	167	3	res	re	NOUN
chd-200	167	4	.	.	PUNCT
chd-200	167	5	october	october	PROPN
chd-200	167	6	2020	2020	NUM
chd-200	167	7	:	:	PUNCT
chd-200	167	8	clincanres.3421.2020	clincanres.3421.2020	NOUN
chd-200	167	9	.	.	PUNCT
chd-200	168	1	doi:10.1158/10780432.ccr-20	doi:10.1158/10780432.ccr-20	NOUN
chd-200	168	2	-	-	PUNCT
chd-200	168	3	3421	3421	NUM
chd-200	168	4	13	13	NUM
chd-200	168	5	.	.	PUNCT
chd-200	169	1	nepogodiev	nepogodiev	PROPN
chd-200	169	2	d	d	PROPN
chd-200	169	3	,	,	PUNCT
chd-200	169	4	bhangu	bhangu	VERB
chd-200	169	5	a	a	DET
chd-200	169	6	,	,	PUNCT
chd-200	169	7	glasbey	glasbey	PROPN
chd-200	169	8	jc	jc	PROPN
chd-200	169	9	,	,	PUNCT
chd-200	169	10	et	et	PROPN
chd-200	169	11	al	al	PROPN
chd-200	169	12	.	.	PUNCT
chd-200	169	13	mortality	mortality	NOUN
chd-200	169	14	and	and	CCONJ
chd-200	169	15	pulmonary	pulmonary	ADJ
chd-200	169	16	complications	complication	NOUN
chd-200	169	17	in	in	ADP
chd-200	169	18	patients	patient	NOUN
chd-200	169	19	undergoing	undergo	VERB
chd-200	169	20	surgery	surgery	NOUN
chd-200	169	21	with	with	ADP
chd-200	169	22	perioperative	perioperative	ADJ
chd-200	169	23	sars	sar	NOUN
chd-200	169	24	-	-	PUNCT
chd-200	169	25	cov-2	cov-2	NOUN
chd-200	169	26	infection	infection	NOUN
chd-200	169	27	:	:	PUNCT
chd-200	169	28	an	an	DET
chd-200	169	29	international	international	ADJ
chd-200	169	30	cohort	cohort	NOUN
chd-200	169	31	study	study	NOUN
chd-200	169	32	.	.	PUNCT
chd-200	170	1	lancet	lancet	NOUN
chd-200	170	2	.	.	PUNCT
chd-200	171	1	2020;396(10243):27	2020;396(10243):27	NUM
chd-200	171	2	-	-	SYM
chd-200	171	3	38	38	NUM
chd-200	171	4	.	.	PUNCT
chd-200	172	1	doi:10.1016	doi:10.1016	PROPN
chd-200	172	2	/	/	SYM
chd-200	172	3	s0140	s0140	PROPN
chd-200	172	4	-	-	PUNCT
chd-200	172	5	6736(20)31182	6736(20)31182	NOUN
chd-200	172	6	-	-	PUNCT
chd-200	172	7	x	x	SYM
chd-200	172	8	14	14	NUM
chd-200	172	9	.	.	PUNCT
chd-200	173	1	kapteijn	kapteijn	PROPN
chd-200	173	2	ba	ba	PROPN
chd-200	173	3	,	,	PUNCT
chd-200	173	4	nieweg	nieweg	PROPN
chd-200	173	5	oe	oe	PROPN
chd-200	173	6	,	,	PUNCT
chd-200	173	7	liem	liem	PROPN
chd-200	173	8	i	i	PROPN
chd-200	173	9	,	,	PUNCT
chd-200	173	10	et	et	PROPN
chd-200	173	11	al	al	PROPN
chd-200	173	12	.	.	PUNCT
chd-200	174	1	localizing	localize	VERB
chd-200	174	2	the	the	DET
chd-200	174	3	sentinel	sentinel	ADJ
chd-200	174	4	node	node	NOUN
chd-200	174	5	in	in	ADP
chd-200	174	6	cutaneous	cutaneous	ADJ
chd-200	174	7	melanoma	melanoma	NOUN
chd-200	174	8	:	:	PUNCT
chd-200	174	9	gamma	gamma	NOUN
chd-200	174	10	probe	probe	NOUN
chd-200	174	11	detection	detection	NOUN
chd-200	174	12	versus	versus	ADP
chd-200	174	13	blue	blue	ADJ
chd-200	174	14	dye	dye	PROPN
chd-200	174	15	.	.	PUNCT
chd-200	175	1	ann	ann	PROPN
chd-200	175	2	surg	surg	PROPN
chd-200	175	3	oncol	oncol	PROPN
chd-200	175	4	.	.	PUNCT
chd-200	176	1	1997;4(2):156160	1997;4(2):156160	NUM
chd-200	176	2	.	.	NOUN
chd-200	176	3	15	15	NUM
chd-200	176	4	.	.	PUNCT
chd-200	177	1	albiges	albige	NOUN
chd-200	177	2	l	l	NOUN
chd-200	177	3	,	,	PUNCT
chd-200	177	4	foulon	foulon	NOUN
chd-200	177	5	s	s	PROPN
chd-200	177	6	,	,	PUNCT
chd-200	177	7	bayle	bayle	PROPN
chd-200	177	8	a	a	PROPN
chd-200	177	9	,	,	PUNCT
chd-200	177	10	et	et	PROPN
chd-200	177	11	al	al	PROPN
chd-200	177	12	.	.	PUNCT
chd-200	177	13	determinants	determinant	NOUN
chd-200	177	14	of	of	ADP
chd-200	177	15	the	the	DET
chd-200	177	16	outcomes	outcome	NOUN
chd-200	177	17	of	of	ADP
chd-200	177	18	patients	patient	NOUN
chd-200	177	19	with	with	ADP
chd-200	177	20	cancer	cancer	NOUN
chd-200	177	21	infected	infect	VERB
chd-200	177	22	with	with	ADP
chd-200	177	23	sars	sar	NOUN
chd-200	177	24	-	-	PUNCT
chd-200	177	25	cov2	cov2	PROPN
chd-200	177	26	:	:	PUNCT
chd-200	177	27	results	result	VERB
chd-200	177	28	from	from	ADP
chd-200	177	29	the	the	DET
chd-200	177	30	gustave	gustave	NOUN
chd-200	177	31	roussy	roussy	ADJ
chd-200	177	32	cohort	cohort	NOUN
chd-200	177	33	.	.	PUNCT
chd-200	178	1	nat	nat	NOUN
chd-200	178	2	cancer	cancer	NOUN
chd-200	178	3	.	.	PUNCT
chd-200	179	1	september	september	PROPN
chd-200	179	2	2020:1	2020:1	NUM
chd-200	179	3	-	-	SYM
chd-200	179	4	11	11	NUM
chd-200	179	5	.	.	PUNCT
chd-200	180	1	doi:10.1038	doi:10.1038	NOUN
chd-200	180	2	/	/	SYM
chd-200	180	3	s43018	s43018	NOUN
chd-200	180	4	-	-	PUNCT
chd-200	180	5	020	020	NUM
chd-200	180	6	-	-	PUNCT
chd-200	180	7	00120	00120	NUM
chd-200	180	8	-	-	PUNCT
chd-200	180	9	5	5	NUM
chd-200	180	10	introduction	introduction	NOUN
chd-200	180	11	materials	material	NOUN
chd-200	180	12	and	and	CCONJ
chd-200	180	13	methods	method	NOUN
chd-200	180	14	results	result	VERB
chd-200	180	15	discussion	discussion	NOUN
chd-200	180	16	acknowledgement	acknowledgement	NOUN
chd-200	180	17	conflicts	conflict	NOUN
chd-200	180	18	of	of	ADP
chd-200	180	19	interest	interest	NOUN
chd-200	180	20	authors	author	NOUN
chd-200	180	21	'	'	PART
chd-200	180	22	contributions	contribution	NOUN